Introduction {#Sec1}
============

Desmosomes are intercellular adhering junctions serving to attach neighbouring cells to each other. They are most numerous in tissues subjected to significant mechanical stress such as the stratified squamous epithelia of the skin (Bizzozero [@CR49]) and of mucous membranes (Farquhar and Palade [@CR107]) as well as the myocardium (Fawcett and Selby [@CR110]). Moreover, desmosomes are found in simple epithelia and in non-epithelial cells such as the meningeal cells of the arachnoidea (Gusek [@CR139]) and the follicular dendritic cells of lymph follicles (Swartzendruber [@CR311]).

Desmosomes were discovered as cell contacts in the middle of the nineteenth century (Calkins and Setzer [@CR67]). By the means of light microscopy, desmosomes were first described in the epidermis by the Italian pathologist Bizzozero in ([@CR49]). In his histology text book, the anatomist Josef Schaffer from Vienna introduced the term "desmosome", by combining the greek words "desmos" (bond) and "soma" (body) although, to that time, he, like most others in the field believed that desmosomes were cytoplasm-filled intercellular bridges (Schaffer [@CR276]). It took almost another century until Keith Porter, using electron microscopy, was able to confirm the basic observation of Bizzozero that desmosomes rather are contacts between adjacent cells and to allow the first description on desmosome ultrastructure (Porter [@CR258]). With these new technical advances at hand, several studies were performed in the following years on the distribution and organization of desmosomes in various tissues. In addition, starting in the 1970s, biochemical approaches and molecular cloning techniques were applied to identify the desmosomal components and to characterize their interactions (Drochmans et al. [@CR96]; Moll et al. [@CR226]; Moll and Franke [@CR225]; Schwarz et al. [@CR286]; Skerrow and Matoltsy [@CR302]).

Significant insights into the regulation of desmosomal adhesion also came from the field of dermatology since it was demonstrated that autoantibodies in patients suffering from the autoimmune blistering skin diseases pemphigus vulgaris (PV), and pemphigus foliaceus (PF), are directed to Ca^2+^-sensitive cell surface proteins within desmosomes (Eyre and Stanley [@CR104], [@CR105]; Jones et al. [@CR169]; Karpati et al. [@CR172]), which were identified as the desmosomal cadherins desmoglein 1 (Dsg 1) and Dsg 3 (Amagai et al. [@CR8]; Koulu et al. [@CR192]). The term "pemphigus" comes from the greek word "pemphix" (blister) and is being used in dermatology since 1791 (Schmidt et al. [@CR284]), long before it was found that pemphigus is associated with autoantibodies against keratinocyte surface antigens (Beutner and Jordon [@CR45]) and that these antibodies are sufficient to cause acantholysis, i.e. loss of cell--cell adhesion, in human skin in vivo and in vitro (Anhalt et al. [@CR22]; Schiltz and Michel [@CR277]). The final break-through was the finding that autoantibodies against the extracellular domains of Dsg 3 and Dsg 1 in PV and in PF are pathogenic (Amagai et al. [@CR12], [@CR10], [@CR9]). Therefore, autoantibodies from pemphigus patients have been used to characterize the mechanisms involved in the regulation of desmosomal adhesion. Except from pemphigus, other diseases in which desmosomal adhesion is altered by mutations or bacterial toxins helped to elucidate the functional role of the different desmosomal components.

During the last past several years, a number of comprehensive reviews have been published on both desmosome structure and function (Dusek et al. [@CR98]; Garrod et al. [@CR123]; Getsios et al. [@CR127]; Green and Simpson [@CR136]; Holthofer et al. [@CR158]; Kitajima [@CR177]; Kottke et al. [@CR191]; Muller et al. [@CR231]; Yin and Green [@CR350]) and/or on the mechanisms involved in pemphigus pathogenesis (Amagai [@CR7]; Hashimoto [@CR148]; Lanza et al. [@CR198]; Payne et al. [@CR250]; Sharma et al. [@CR292]; Sitaru and Zillikens [@CR301]; Stanley and Amagai [@CR308]), which indicates that the perspective of the existing model of the desmosome and its role in pemphigus pathogenesis are constantly reshaped. Moreover, because even textbook knowledge such as on the molecular composition of myocardial intercalated discs needs revision (Borrmann et al. [@CR56]; Franke et al. [@CR115]), it becomes obvious that after almost 150 years of desmosome research, our knowledge is still far from complete. This article focuses on the mechanisms regulating desmosomal adhesion, which are compromised in diseases such as pemphigus.

The ultrastructure and composition of desmosomes {#Sec2}
================================================

The first detailed analysis of desmosome ultrastructure was provided by Odland ([@CR243]). Desmosomes are discoid junctions with a diameter of about 0.2--0.5 μm and are composed of two electron-dense plaques in each of the two cells which are separated by an intercellular cleft of 24--30 nm (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}) (Farquhar and Palade [@CR107]; Odland [@CR243]). Within the plaques, an outer dense plaque can be separated from a less dense inner plaque, the latter of which is linked to loops of intermediate filament bundles (Kelly [@CR174]). Desmosomes contain members of at least three protein families. Desmosomal cadherins form the intercellular adhesive interface, whereas armadillo and plakin family proteins built up the plaques. It is believed that the cytoplasmic tail of Dsgs and Dscs interact with plakoglobin which in turn binds to desmoplakin (Fig. [1](#Fig1){ref-type="fig"}). Desmoplakin finally is anchored to the intermediate filament cytoskeleton (Green and Simpson [@CR136]). These interactions seem to be stabilized laterally by plakophilin (Hatzfeld [@CR150]). Fig. 1Molecular model of the desmosome. The desmosomal cadherins desmoglein and desmocollin undergo homophilic and heterophilic binding via interaction with the amino-terminal extracellular (*EC*) 1 domain of partner molecules on the same (*cis*) as well as on the neighbouring cell (*trans*). The cytoplasmic domains are largely embedded in the outer dense plaque (ODP) where they are associated with plakoglobin and plakophilin. In the inner dense plaque (*IDP*), desmoplakin links these adaptor molecules to the intermediate filament cytoskeletonFig. 2Ultrastructure of the desmosome. The electron micrograph of a keratinocyte desmosome shows the desmosomal plaque with inserting cytokeratin intermediate filaments as well as some fuzzy material within the extracellular space likely reflecting the extracellular domains of desmosomal cadherins

Desmosomes and desmosome-like junctions {#Sec3}
=======================================

Adhering junctions are divided into two main forms: (1) desmosomes, which serve as anchoring structures for intermediate filaments to desmosomal cadherins, and (2) adherens junctions, which contain cell-type specific adhesion molecules from the cadherin super-family that are linked to the actin cytoskeleton. Both, desmosomes and adherens junctions can be found as constituents of more elaborated cell contact complexes. Moreover, chimeric cell contacts exist which share features of both adherens junctions and desmosomes.

Junctional complexes {#Sec4}
--------------------

Polarized epithelial cells display junctional complexes located at the uppermost section of the baso-lateral membrane. In apico-basal direction, the complex is composed of the zonula occludens (tight junction), the zonula adherens and a desmosome (macula adherens) (Farquhar and Palade [@CR107]). Accompanied by a line of separated desmosomes, the zonula occludens and the zonula adherens span the entire cell by forming continuous junction belts. These junctional complexes are regarded as hallmarks of polarized epithelial cells but differ in terms of size and ultrastructure in cell type-specific manner.

Area composita {#Sec5}
--------------

The intercalated discs of the myocardium also consist of three types of cell junctions, i.e. adherens junctions, desmosomes and gap junctions (Fig. [3](#Fig3){ref-type="fig"}). Although "transitional forms" between adherens junctions and desmosomes were described in the very beginning (Fawcett and Selby [@CR110]), most morphological studies regarded the intercalated discs to be composed of separated desmosomes and adherens junctions, the former linked to the desmin type intermediate filament cytoskeleton and the latter to actin filaments of the myofibrills (Fig. [3](#Fig3){ref-type="fig"}) (Fawcett and McNutt [@CR109]; McNutt and Fawcett [@CR213]; Shimada et al. [@CR294]). This view seemed to be supported by immuno-localization studies, which showed that desmoplakin as a desmosomal marker and the myocardial adherens junction protein N-cadherin displayed mutually exclusive spatial distribution patterns (Angst et al. [@CR21]; Gutstein et al. [@CR140]). However, a recent comprehensive set of studies unequivocally demonstrated that the desmosomal components desmoglein 2 (Dsg 2), desmocollin 2 (Dsc 2), desmoplakin and plakophilin-2 as well as the adherens junction components N-cadherin, cadherin-11, α-catenin and β-catenin, afadin, vinculin and ZO-1 are present in all parts of intercalated discs irrespective of whether their ultrastructure resembles more closely typical desmosomes or adherens junctions (Borrmann et al. [@CR56]; Franke et al. [@CR115]). It seems that the two types of junctions coalesce within the first-year postpartum and that plakophilin 2 is of special importance for junction integrity (Pieperhoff and Franke [@CR255]; Pieperhoff et al. [@CR256]). Therefore, the intercalated discs were now reclassified as "area composita", a mixed type of adhering junctions. Fig. 3Ultrastructure of the area composita of a myocardial intercalated disc. The electron micrograph shows an intercalated disc containing a gap junction (*GJ*) in its longitudinal section as well as an adhering junction with an extensive electron-dense plaque in the section perpendicular to the cellular axis. Note that insertion of actin filaments, which is typical for adherens junctions, is present in some parts of the junction (*asterisk*) but not in others (*hash key*). Based on the recent finding that all parts of these adhering junctions contain the same set of desmosomal components, they are now defined as area composita

Complexus adhaerentes and meningeal junctions {#Sec6}
---------------------------------------------

Lymphatic endothelial cells in certain lymphatic vessels and in the sinus of lymph nodes form a kind of chimeric cell contact, which contains components from desmosomes (desmoplakin, plakoglobin), adherens junctions (VE-cadherin, α-catenin, β-catenin, afadin) as well as from tight junctions (claudin-5 and ZO-1) (Hammerling et al. [@CR142]; Schmelz and Franke [@CR278]; Schmelz et al. [@CR281]). The ultrastructure of complexus adhaerentes shares features of both adherens junctions and desmosomes. Complexus adhearentes form continuous belt-like junctions similar to adherens junctions of vascular endothelial cells, whereas their junctional plaques are more similar to desmosomes. It was proposed that plakoglobin in these contacts is responsible for recruitment of desmoplakin (Kowalczyk et al. [@CR197]). Recently, in meningeoma cells, a new type of adhering junctions was discovered in which adherens junctions also contained the desmosomal plaque protein plakophilin 2 (Akat et al. [@CR3]).

The desmosomal components {#Sec7}
=========================

Desmosomal cadherins {#Sec8}
--------------------

The desmosomal members of the cadherin superfamily, desmogleins (Dsg 1--4) and desmocollins (Dsc 1--3), are single-pass transmembrane glycoproteins, which mediate adhesion in Ca^2+^-dependent manner (Buxton et al. [@CR62]; Garrod et al. [@CR123]; Getsios et al. [@CR127]; Nollet et al. [@CR240]). Desmosomal adhesion molecules have been first isolated from desmosomal intercellular regions (Gorbsky and Steinberg [@CR132]). Using specific antibodies to localize proteins at the cell surface and to inhibit desmosome formation, Dsc 1 (130 kDa) and Dsc 2 (115 kDa) were shown to be directly involved in cell--cell adhesion (Cowin et al. [@CR87]) and later on were identified to be cadherin family proteins (Collins et al. [@CR86]; Koch et al. [@CR184]). Similarly, Dsg 1 (165 kDa), Dsg 2 (116 kDa), Dsg 3 (130 kDa) and Dsc 3 (110 kDa) were characterized (Amagai et al. [@CR8]; Arnemann et al. [@CR28]; Jones et al. [@CR168]; King et al. [@CR176]; Koch et al. [@CR183], [@CR182]; Schafer et al. [@CR275]; Schmelz et al. [@CR279], [@CR280]). More recently, Dsg 4 (108 kDa) was found to be the principal Dsg expressed in hair follicles (Kljuic et al. [@CR181]; Whittock and Bower [@CR336]). The genes encoding desmosomal cadherins, which share an amino acid identity of approximately 30--50%, both with each other and with classical cadherins, are all located on chromosome 18 in humans (Cowley et al. [@CR89]). Mouse models revealed that Dsg 2 and Dsc 3 are the most important desmosomal cadherin members because deficiency caused embryonic lethality (Table [1](#Tab1){ref-type="table"}) (Den et al. [@CR91]; Eshkind et al. [@CR102]). Because lethality induced by Dsc 3 deficiency occurred before mature desmosmes were formed, and because Dsg 2 was observed to be also localized outside of desmosomes in embryonal stem cells, non-desmosmal functions of Dsc 3 and Dsg 2 seemed to be responsible in this context. In contrast, ablation of cadherins with more restrictive expression patterns such as Dsc 1 led to localized superficial epidermal acantholysis or mucosal and deep epidermal splitting in traumatized skin accompanied by hair loss in the case of Dsg 3 (Chidgey et al. [@CR75]; Koch et al. [@CR185]). Dsg 4 mutations are followed primarily by defective hair formation (Kljuic et al. [@CR181]). Table 1Desmosome-associated diseases in humans and in transgenic mouse modelsMouse modelDesmosomal componentHuman diseaseInactivationGenetic alteration--Dsg 1Striate palmoplantar keratoderma (SPPK)\
(Rickman et al. [@CR261])Embryonic lethality\
Defective stem cell proliferation\
(Eshkind et al. [@CR102])Dsg 2Arrhythmogenic right ventricular cardiomyopathy (ARVC)\
(Pilichou et al. [@CR257])Suprabasal epidermal acantholysis\
Oral erosions\
Hair loss\
(Koch et al. [@CR185])Dsg 3--Impaired hair keratinisation\
Hyperproliferation\
(Kljuic et al. [@CR181])Dsg 4Hypotrichosis\
(Kljuic et al. [@CR181])Epidermal granular layer acantholysis\
Impaired barrier function\
Hyperproliferation\
(Chidgey et al. [@CR75])Dsc 1----Dsc 2Arrhythmogenic right ventricular cardiomyopathy (ARVC)\
(Syrris et al. [@CR313]; Heuser et al. [@CR400])Embryonic lethality\
(Den et al. [@CR91])Dsc 3--Embryonic lethality\
Myocardial fragility\
Epidermal subcorneal acantholysis\
(Bierkamp et al. [@CR47], [@CR48]; Ruiz et al. [@CR266])PlakoglobinNaxos disease:\
Arrhythmogenic right ventricular cardiomyopathy (ARVC)\
Palmoplantar keratoderma\
Woolly hair\
(McKoy et al. [@CR211])Embryonic lethality\
Defects in heart, skin, blood vessels\
Neuroepithelium\
(Gallicano et al. [@CR120], [@CR121]DesmoplakinArrhythmogenic right ventricular cardiomyopathy (ARVC)\
(Rampazzo et al. [@CR260])\
Striate palmoplantar keratoderma (SPPK)\
(Armstrong et al. [@CR27]; Whittock et al. [@CR337])\
Carvajal syndrome:\
Dilated left ventricular cardiomyopathy\
Striate palmoplantar keratoderma (SPPK)\
Woolly hair\
(Norgett et al. [@CR241])\
Lethal acantholytic epidermolysis bullosa:\
-suprabasal epidermal blistering\
-universal alopecia\
-nail loss\
(Jonkman et al. [@CR170])--Plakophilin 1Ectodermal dysplasia and skin fragility syndrome:\
Skin blistering around mouth, on soles and palms\
(McGrath [@CR210])Embryonic lethality\
Heart defects\
(Grossmann et al. [@CR137])Plakophilin 2Arrhythmogenic right ventricular cardiomyopathy (ARVC)\
(Gerull et al. [@CR125])Bacterial toxinsSuperficial epidermal acantholysis\
(Melish and Glasgow [@CR214]; Amagai et al. [@CR16], [@CR17])Dsg 1Staphylococcus scalded skin syndrome:\
Superficial skin splitting\
Fever, erythema\
Skin tenderness\
(first described by Ritter von Rittershain 1878)AutoantibodiesSuperficial epidermal acantholysis\
(Amagai et al. [@CR12])Dsg 1Pemphigus foliaceus (PF)\
Superficial epidermal acantholysis\
Pemphigus vulgaris (PV, mucocutaneous)\
Suprabasal epidermal acantholysis\
Mucosal erosions (mouth, larynx, nasal cavity, vagina)\
(Lever [@CR200]; Koulu et al. [@CR192]; Amagai et al. [@CR8])Suprabasal epidermal acantholysis\
Mucosal erosions\
(Anhalt et al. [@CR22]; Amagai et al. [@CR9]; Mahoney et al. [@CR205])Dsg 3Pemphigus vulgaris (PV, mucosal dominant)\
Suprabasal epidermal acantholysis\
(Lever [@CR200]; Amagai et al. [@CR8])

### The structure of desmosomal cadherins {#Sec9}

Desmosomal cadherins are type I integral membrane proteins. The amino-terminal extracellular domain of desmosomal cadherins consists of four cadherin repeats (EC1--4) of about 110 amino acids followed by a less related membrane-proximal domain (EC 5) (Dusek et al. [@CR98]). Based on the crystal structure of classical cadherins (Boggon et al. [@CR51]; Overduin et al. [@CR245]; Shapiro et al. [@CR291]), the EC 1--4 domains are thought to be connected via flexible linkers which are rigidified by binding of up to three Ca^2+^ ions each (Pertz et al. [@CR254]). In the cytoplasmic domain, a juxtamembranuous anchor (IA) region is located which, at least in the case of Dsc 1a, contains a desmoplakin-binding element (Troyanovsky et al. [@CR317]) and maybe be involved in binding and trafficking of p120catenin similar to its role in E-cadherin (Miranda et al. [@CR222]). The following cadherin-typical sequence (ICS) is required for binding to plakoglobin (Mathur et al. [@CR208]; Troyanovsky et al. [@CR316]). For desmocollins, in which a long and short "a" and "b" isoform is generated by alternative splicing (Collins et al. [@CR86]), it has been shown that the ICS domain is lacking in the b isoform which therefore is unable to bind plakoglobin but instead associates with plakophilin 3 (Bonne et al. [@CR53]; Troyanovsky et al. [@CR315]). The functions of the C-terminal proline-rich linker (L), the Dsg-specific repeated unit domains (RUDs) and the desmoglein terminal domain (DTD), which are all only present in desmogleins, are not clear (Dusek et al. [@CR98]).

### The Ca^2+^-dependency of desmosomal cadherin-mediated binding {#Sec10}

It is well established that binding of desmosomal and classical cadherins is strictly Ca^2+^-dependent (Chitaev and Troyanovsky [@CR76]; Heupel et al. [@CR157]; Pertz et al. [@CR254]; Waschke et al. [@CR333]). For Dsg 1, Ca^2+^-dependency of homophilic binding has been characterized in more detail. It was found that the Ca^2+^ concentration for half-maximal binding activity of Dsg 1 is 0.8 mM Ca^2+^and that binding is highly cooperative with the Hill coefficient being ≥5 (Waschke et al. [@CR333]). This indicates that Dsg 1 binding is strong only at extracellular Ca^2+^concentrations higher than 0.8 mM. Although the exact extracellular Ca^2+^concentration within the epidermis is unknown, it has been shown that a gradient exists with low Ca^2+^concentrations in the basal layers and high concentrations in the superficial epidermis (Elias et al. [@CR100]; Menon and Elias [@CR216]). Therefore, if homophilic binding of Dsg 1 occurs in vivo, it has to be considered that it may contribute to effective intercellular adhesion only in the superficial epidermis.

### Transinteraction mechanisms of desmosmal cadherins {#Sec11}

At present, it is still a matter of debate how desmosmal cadherins interact with each other in vivo. However, several lines of evidence indicate that the N-terminal EC 1 domain is important. Similar to classical cadherins, desmosomal cadherins contain a cell adhesion recognition (CAR) site containing a central alanine residue (Blaschuk et al. [@CR50]). However, instead of the conserved tripeptide HAV sequence of classical cadherins, the sequence is YAT for Dsc 1 and RAL for Dsg 1, respectively (Tselepis et al. [@CR319]). Peptides derived from these sequences were able to block homophilic adhesion mediated by Dsg 1 and Dsc 1 and to inhibit desmosomal adhesion in epithelial cells when the peptides for Dsg 1 and Dsc 1 were applied together, indicating that the CAR site in the EC 1 domain is critical for maintenance of desmosmal adhesion (Runswick et al. [@CR268]; Tselepis et al. [@CR319]). This hypothesis is supported by studies in which mechanisms underlying the loss of keratinocyte cohesion in pemphigus were investigated. AK23, a monoclonal Dsg 3 antibody from a PV mouse model directed against the predicted binding motif of the EC 1, has been shown to be pathogenic in vivo whereas antibodies targeting other parts of the Dsg 3 extracellular domain were not (Tsunoda et al. [@CR320]). Together with the recent finding that AK 23 similar to Dsg 3 antibodies from PV patients, which are known to be also primarily directed against the N-terminal part of EC 1 (Sekiguchi et al. [@CR290]), is able to directly interfere with Dsg 3 binding (Heupel et al. [@CR157]), these data demonstrate that interaction of EC 1 is crucial for Dsg 3 binding. In addition to these functional studies, morphologic studies sought to address the mode of desmosomal cadherin interaction within desmosomes by using electron tomography imaging of epidermal tissue (Al-Amoudi et al. [@CR5]; He et al. [@CR153]). Based on predictions from the C-cadherin crystal structure, He and colleagues reported that in mouse epidermis several desmosomal cadherins form knots in which cadherins display stochastic arrangement. In these knots, desmosomal cadherins seemed to interact via their EC 1 domains with both molecules on the same cell in *cis* as well as with molecules from opposing cells in trans (He et al. [@CR153]). Al-Amoudi and co-workers refined the technique by employing cryo-electron microscopy in human epidermis. They confirmed *cis*- and *trans*-interactions of the EC 1 domains, possibly via insertion of the tryptophane 2 into the hydrophobic pocket of the CAR site (Al-Amoudi et al. [@CR5]). However, they found that *cis*-interactions of the EC 4--5 regions may also occur and that desmosomal cadherins rather show periodically zipper-like arrangements similar to classical cadherins (Boggon et al. [@CR51]).

### Homophilic and heterophilic binding of desmosomal cadherins {#Sec12}

In contrast to classical cadherins from adherens junctions which primarily bind in homophilic manner, data indicate that desmosomal cadherins undergo both homophilic and heterophilic transinteraction. Using EC 1--2 fragments of Dsg 2 and Dsc 2, it was shown that homophilic binding occurs in vitro (Syed et al. [@CR312]). Similarly, homophilic binding of Dsg 3 was found (Amagai et al. [@CR11]). When recombinant proteins consisting of the complete extracellular domain were used for atomic force microscopy (AFM) measurements, it was demonstrated that the unbinding force of single homophilically transinteracting molecules was about 37--68 pN (depending on the retrace velocity 300--6,000 nm/s) for Dsg 1 with a lifetime of 0.17 s and about 50 pN for Dsg 3 (Heupel et al. [@CR157]; Waschke et al. [@CR331], [@CR333]), which is in the same range as observed for other types of cadherins characterized by the same method such as VE-cadherin, N-cadherin or LI-cadherin (Baumgartner et al. [@CR34], [@CR33]; Wendeler et al. [@CR335]). These data indicate that the molecular binding properties of homophilic adhesion of desmosomal cadherins may be comparable to other cadherins.

Heterophilic binding of Dsg 2 to Dsc 1 or Dsc 2 was also found on the molecular level (Chitaev and Troyanovsky [@CR76]; Syed et al. [@CR312]) but no interaction of Dsg 1 with Dsg 3 (Heupel et al. [@CR157]). Aggregation assays of transfected cells indicated that in cells, heterophilic binding of Dsgs and Dscs might be of even greater importance than homophilic binding to induce strong intercellular adhesion (Kowalczyk et al. [@CR194]; Marcozzi et al. [@CR207]; Runswick et al. [@CR268]) and that adhesion is strictly dependent on the ratio of the respective Dsgs and Dscs (Getsios et al. [@CR126]). This view is supported by the recent finding that a conditional Dsc 3-deficiency in mice induced a severe pemphigus-like phenotype with epidermal blistering (Chen et al. [@CR70]). Because antibodies in typical pemphigus are usually not directed against Dsc 3 but against Dsg 1 and Dsg 3, it has to be considered that heterophilic binding of these three molecules is important for epidermal cohesion in vivo.

Armadillo family proteins {#Sec13}
-------------------------

From the Armadillo family, plakoglobin and plakophilins 1--3 are important components of desmosomes.

### Plakoglobin {#Sec14}

Plakoglobin (82 kDa), also termed γ-catenin, is the only essential desmosomal component which is also found in typical adherens junctions (Cowin et al. [@CR88]; Franke et al. [@CR114], [@CR113]). The gene encoding for plakoglobin was mapped to chromosome 17 (Aberle et al. [@CR1]). Plakoglobin binds to the cytoplasmic cadherin-typical sequence of Dsgs and Dscs via its first three armadillo repeat domains (Chitaev et al. [@CR77]). Because the same binding site is required for interaction of plakoglobin to α-catenin, the latter is excluded from desmosomes. Similarly, although the armadillo repeat domain of β-catenin can also bind to Dsg 2, its flanking domains inhibit this interaction, which may explain the absence of β-catenin from desmosomes (Troyanovsky et al. [@CR318]; Wahl et al. [@CR327]). Plakoglobin has been demonstrated to interact with other desmosomal plaque components such as desmoplakin, plakophilins and also with cytokeratin filaments (Bonne et al. [@CR53]; Chen et al. [@CR69]; Kowalczyk et al. [@CR195]; Smith and Fuchs [@CR303]). The importance of this linker function can be concluded from studies in which inactivation of plakoglobin led to embryonic lethality due to mechanical fragility of the myocardium and, when mice are viable, to subcorneal skin blistering indicating that plakoglobin is essential for desmosomal stability (Table [1](#Tab1){ref-type="table"}) (Bierkamp et al. [@CR47]; Ruiz et al. [@CR266]).

Besides its function as a desmosomal adaptor protein, plakoglobin seems to be involved in nuclear signalling. It has been shown that plakoglobin, comparable to β-catenin in the canonical wnt signalling pathway, confers transcriptional activity together with TCF-4/LEF transcription factors (Maeda et al. [@CR204]). This mechanism seems to interfere with β-catenin-mediated transcription (Hu et al. [@CR159]). Because plakoglobin like β-catenin is a target of glycogen synthase kinase-3 β, which drives proteosomal degradation of both proteins (Kodama et al. [@CR186]; Muller et al. [@CR231]; Williamson et al. [@CR341]), a complex pattern of direct and indirect transcriptional regulation seems likely. A target gene of Lef-1/plakoglobin signalling is c-Myc, the expression of which was inhibited in keratinocytes but enhanced in transformed rat kidney epithelial cells (Kolligs et al. [@CR188]; Kolly et al. [@CR189]; Williamson et al. [@CR341]). This indicates that the role of plakoglobin transcriptional regulation is strictly cell type-dependent. In keratinoytes, c-Myc repression by plakoglobin is required to stop proliferation and to allow terminal differentiation (Williamson et al. [@CR341]). Another potential target gene is the anti-apoptotic molecule Bcl--X~L,~ which was found to be upregulated in plakoglobin-deficient cells leading to reduced apoptosis and thus might also be repressed by plakoglobin (Dusek et al. [@CR97]). Taken together, plakoglobin serves as functional linker between intercellular adhesion and regulation of the cell cycle. This might also be important for cancer progression because many tumors are characterized by loss of plakoglobin expression.

### Plakophilins {#Sec15}

Plakophilin 1 (80 kDa) was first identified as an "accessory" plaque protein because, in contrast to plakoglobin and desmoplakin, it was found in cells from certain stratified and complex epithelia only (Franke et al. [@CR113]; Hatzfeld et al. [@CR151]; Heid et al. [@CR154]). Afterwards, it became clear that plakophilin 2 (100 kDa) is ubiquitously present in all desmosomes and also plakophilin 3 (87 kDa) is present in most simple and stratified epithelia (Mertens et al. [@CR219]; Schmidt et al. [@CR283]). The genes encoding plakophilin 1, 2 and 3 are located on chromosomes 1, 12, and 11, respectively (Bonne et al. [@CR52]). Plakophilin 1 and 2 exist in two splice variants with a shorter "a" and a longer "b" form (Mertens et al. [@CR218]; Schmidt et al. [@CR282]). In addition to their localization in desmosomes, plakophilins 1 and 2 are also found in the karyoplasm in a variety of cells and plakophilin 1 b is exclusively located in the nucleus. Plakophilin 2 deficiency leads to embryonic death due to heart defects indicating that the presence of at least one member of the plakophilin family is required (Table [1](#Tab1){ref-type="table"}) (Grossmann et al. [@CR137]). Under these conditions, cytokeratin filaments were retracted from cell borders and desmoplakin was localized in the cytoplasm rather than at desmosomes in cardiomyocytes, demonstrating the relevance of plakophilin 2 to desmosplakin recruitment. Because cardiomyocytes in contrast to epithelial cells express only plakophilin 2 but not plakophilin 1 and 3, defects were present in the heart only, whereas epithelia were not affected.

Plakophilins can directly interact with all other desmosomal components including cytokeratins via the aminoterminal head domain (Bonne et al. [@CR53]; Hatzfeld [@CR150]; Hatzfeld et al. [@CR152]). Plakophilin 1 recruits desmosomal components to the cell membrane, increases size and number of desmosomes and therefore seems to be a scaffolding protein, which induces desmosome assembly (Hatzfeld et al. [@CR152]; Kowalczyk et al. [@CR196]; Wahl [@CR326]). On the other hand, because plakophilin 1 is located in the dense inner desmosomal plaque whereas cytokeratin filaments only loop into the outer plaque, it is believed that plakophilin 1 enhances desmoplakin lateral interactions but does not directly associate with cytokeratin filaments in vivo (Hatzfeld [@CR150]; North et al. [@CR242]). It has been demonstrated that desmosome formation is mediated by the aminoterminal domain, whereas recruitment of plakophilin 1 itself to the plasma membrane is dependent on the carboxyterminal region (Sobolik-Delmaire et al. [@CR304]).

In addition to its function in the regulation of desmosome assembly, plakophilins may also regulate signalling mechanisms, both at cell borders as well as in the nucleus. Plakophilin 1 associates with actin filaments at cell borders and has been reported to interact with a GTP exchange factor (GEF) for Rho and thereby could regulate activity of Rho GTPases similar to the closely related p120-catenin, which is known to inhibit Rho A and to activate Rac 1 and Cdc42 (Anastasiadis and Reynolds [@CR20]; Hatzfeld [@CR150]). In addition to their localization within the desmosomal plaque, plakophilin 1 and 2 are also present inside nucleus and plakophilin 2 has been found to be part of the polymerase III complex which is responsible for generation of tRNA and rRNA (Mertens et al. [@CR220]). By these two mechanisms, it is possible that plakophilins may regulate cell adhesion and cell growth (Hatzfeld [@CR150]).

Plakin family proteins {#Sec16}
----------------------

Plakin family proteins are linkers between the cytoskeleton and cell--cell or cell--matrix contacts (Jefferson et al. [@CR166]). Desmoplakin, which exists in two spice variants of a protein encoded by a single gene on chromosome 6 (desmoplakin I: 322 kDa; desmoplakin II: 259 kDa), is an essential component of the desmosomal plaque and therefore is regarded as the prototype of this family (Armstrong et al. [@CR27]; Hatsell and Cowin [@CR149]; Mueller and Franke [@CR228]; Sonnenberg and Liem [@CR305]). Other members such as plectin, envoplakin and periplakin were also found in desmosomes, but their significance for the structure and function of desmosomes is less clear. Especially, plectin is primarily important in hemidesmosmes, which anchor epithelia to the extracellular matrix.

Desmoplakin consists of an aminoterminal plakin domain, which can interact with all other desmosomal plaque proteins such as plakoglobin and plakophilins but also with Dsc 1a (Kowalczyk et al. [@CR195]; Smith and Fuchs [@CR303]; Troyanovsky et al. [@CR317]). The central coiled-coil rod domain, which is important for dimerization, is followed by the carboxyterminal tail consisting of three globular subdomains with several plakin-repeats, which serve as linkers for different intermediate filament types (Choi et al. [@CR78]; Green et al. [@CR135]; Stappenbeck and Green [@CR310]). It is well established that desmoplakin is the main linker protein between the desmosomal cadherin--plakoglobin complex and the intermediate filament cytoskeleton. This has been shown in vitro and was ultimately demonstrated in desmoplakin-deficient mice, which had a reduced number of desmosomes and died at embryonic stage just after implantation (Table [1](#Tab1){ref-type="table"}) (Bornslaeger et al. [@CR54]; Gallicano et al. [@CR120]). Similar to the findings in epidermal-specific desmoplakin-deficient mice, which suffered from skin blistering, desmosomes were not anchored to intermediate filaments (Vasioukhin et al. [@CR323]). Moreover, when desmoplakin was rescued in extraembryonic tissues so that embryos further developed, defects were present not only in the myocardium and epidermis but also in the vasculature and in the neuroepithelium, underlining the importance of desmoplakin for tissue differentiation (Gallicano et al. [@CR121]).

Diversity of desmosomes in different tissues and specific epithelial layers {#Sec17}
---------------------------------------------------------------------------

Although it was discovered about 25 years ago that the structure of desmosomes is not identical in all types of cells and tissues (Giudice et al. [@CR129]; Jones et al. [@CR169]), the knowledge on the diversity of desmosomes is still uncomplete and matter of discussion (Garrod et al. [@CR123]; Getsios et al. [@CR127]; Green and Simpson [@CR136]; Hatzfeld [@CR150]; Holthofer et al. [@CR158]; Kottke et al. [@CR191]; Yin and Green [@CR350]). The diversity of desmosomes has implications for tissue differentiation and also is of high-medical relevance because diseases caused by genetic alteration of or by an autoimmune reponse against a specific desmosomal component may affect only certain but not all desmosome-containing tissues.

Some desmosomal components such as Dsg 2, Dsc 2 and the plaque proteins desmoplakin, plakoglobin and plakophilin 2 are ubiquitously expressed in all cells and tissues in which desmosomes are found. Plakophilin 3 is present in most simple epithelia except hepatocytes as well as in stratified epithelia, whereas plakophilin 1 is restricted to stratified and complex epithelia. In epithelia, the desmosomal cadherins show typical expression patterns. Simple epithelia and urothelium usually express Dsg 2 and Dsc 2 only. Apparently, exceptions are the additional presence of Dsg 1 in the mucosa of uterus, stomach, intestine and in epithelia of liver and pancreas as well as the expression of Dsc 1 in intestine and liver or Dsc 3 in stomach, prostate, salivary gland and urothelium. Dsg 4 has a unique tissue distribution in skin and several simple epithelia such as those present in pancreas, salivary glands, testis, prostate and hepatic epithelium.

The Dsg 1/Dsc 1 and Dsg 3/Dsc 3 pairs are largely confined to stratified epithelia where the expression patterns of the Dsg and Dsc isoforms usually conform. Interestingly, in the stratified corneal epithelium, only Dsg 1 and Dsc1 are present indicating that these desmosomal cadherins in the absence of Dsg 1 and Dsg 3 are sufficient to maintain cohesion in stratified epithelia also. In the epidermis, the plaque proteins plakoglobin, desmoplakin and plakophilin 3 are expressed in all layers (Fig. [4](#Fig4){ref-type="fig"}). In contrast, plakophilins 1 and 2 display inverse distribution with plakophilin 1 being more abundant in the superficial epidermis. These inverse expression patterns are also typical for the Dsg 1/Dsc 1 and Dsg 3/Dsc 3 pairs. Dsg 1/Dsc 1 are the predominant desmosomal cadherins in the superficial epidermis, whereas Dsg 3/Dsc 3 are primarily expressed in the lower epidermis. In contrast to Dsg 1, which can be detected in some desmosomes in keratinocytes of the basal layer also, Dsc 1 and Dsg 4 are absent in the basal layer (Dusek et al. [@CR98]; Mahoney et al. [@CR206]; Spindler et al. [@CR307]). Because Dsg 3 is expressed throughout the spinous layers (Fig. [5](#Fig5){ref-type="fig"}), the expression patterns of Dsg 1 and Dsg 3 largely overlap in human adult epidermis (Mahoney et al. [@CR206]; Spindler et al. [@CR307]). Dsc 2 is enriched in the deep epidermis with lower levels in the superficial epidermis, whereas Dsg 2 is restricted to basal and suprabasal cells but is present in very faint amounts only (Mahoney et al. [@CR206]) indicating that this pair of proteins may be primarily important for cell cohesion in simple epithelia and myocardium rather than in complex epithelia. However, it is unclear at present which desmosomal cadherin isoforms are capable to heretophilically bind to each other and thus interpretation of these distribution patterns with respect to their relevance for mechanical adhesion is preliminary. In multilayered squamous epithelium of mucous membranes, for instance of the oral cavity, Dsg 1 and Dsg 3 are strongly expressed throughout all layers, whereas Dsg 4 shows strong expression in superficial layers but is missing in the basal layer (Mahoney et al. [@CR206]). Fig. 4Expression patterns of desmosomal components in the epidermis. The schematic drawing of the epidermis (*left*) indicates the basal (*BL*), spinous (*SL*), granular (*GL*) and corneal (*CL*) layer of the epidermis. On the right, the expression patterns of desmosomal components in the specific epidermal layers are illustrated. For instance, Dsg 1 and Pkp 1 are most prominent in the superficial layers, whereas expression of Dsg 3 and Dsc 3 is strongest in the deep epidermis. *Dsg* desmoglein, *Dsc* desmocollin, *Pkp* plakophilin, *PG* plakoglobin, *DP* desmoplakinFig. 5Immunostaining of Dsg 1 and Dsg 3 in human epidermis. Intact human epidermis was immunostained using monoclonal antibodies against Dsg 1 (**a**) and Dsg 3 (**b**). A merge of both panels is shown in c. Dsg 1 is most abundant in the superficial epidermis but is also present in the basal layer. Dsg 3 is expressed in the basal layer as well as throughout the spinous layer indicating that in human epidermis the expression patterns of these two proteins broadly overlap. *Scale bar* is 20 μm

It is important to note that the specific distribution patterns of desmosomal components in stratified epithelia are important for epithelial differentiation and function (Green and Simpson [@CR136]). It was shown that forced overexpression of Dsg 3 in the suprabasal epidermis led to abnormal differentiation and hyperproliferation as well as perinatal lethality due to transepidermal water loss (Elias et al. [@CR99]; Merritt et al. [@CR217]). Similarly, forced suprabasal Dsg 2 and Dsc 3 overexpression resulted in hyperproliferation and formation of papillomas, possibly via altered β-catenin/wnt signalling (Brennan et al. [@CR59]; Hardman et al. [@CR145]).

Desmosome assembly and disassembly {#Sec18}
==================================

The mechanisms participating in desmosome assembly and disassembly have been reviewed in detail elsewhere (Getsios et al. [@CR127]; Green and Simpson [@CR136]; Kitajima [@CR177]; Yin and Green [@CR350]). For instance, extracellular Ca^2+^and protein kinase C (PKC) signalling are well known to be involved in desmosome assembly. Ca^2+^concentrations \>0.1 mM allow formation of adherens junctions and desmosomes (Hennings and Holbrook [@CR155]). Desmosomal plaques with inserted cytokeratin filaments became visible as early as after 5 min after the Ca^2+^ switch followed by appearance of assymetrical desmosomes after 10 min and of symmetric desmosomes after 1 h. Increased extracellular Ca^2+^ induced incorporation of desmosomal components such as Dsgs, plakoglobin and desmoplakin into the desmosomal plaque (Hennings and Holbrook [@CR155]; Pasdar et al. [@CR249]; Pasdar and Nelson [@CR247], [@CR248]). Activation of PKC is required for translocation of desmosomal components to the cell membrane and for desmosome assembly (Sheu et al. [@CR293]), but also was found to reduce desmosomal adhesion and to increase Ca^2+^-dependence of desmosomes (Kimura et al. [@CR175]) indicating that regulation of desmosomal adhesion by PKC is complex.

Before desmosome assembly, adhesion zippers of E-cadherin-containing puncta form on filopodial processes of neighbouring cells, an event that requires both α-catenin and VASP-driven actin reorganization (Vasioukhin et al. [@CR323]). Afterwards, these intermediate junctions mature to adherens junctions and desmosomes are assembled at regions where membranes are brought together. It appears that Dscs initiate the formation of desmosomes. This is based on the observations that Dsc 2 is the first desmosomal component at the cell surface followed by Dsg 2 in MDCK cells (Burdett and Sullivan [@CR60]) and that, in keratinocytes, N-terminally deleted Dsc 3, which compromised desmosome formation was still able to bind to β-catenin. Therefore, it can be speculated that Dsc 3 could localize to pre-existing adherens junctions to induce desmosome formation (Hanakawa et al. [@CR143]). Desmosomal cadherins seem to be transported in vesicles from the Golgi along microtubules whereas non-membranous cytoplasmic particles containing desmoplakin and plakophilin are associated with intermediate filaments and move towards cell-junctions by actin-based motility (Godsel et al. [@CR131]; Green and Simpson [@CR136]). Desmoplakin trafficking seems to be dependent on intracellular Ca^2+^ levels because patients with Darier's disease, which results from mutations in a sarcoplasmic reticulum Ca^2+^ pump show desmoplakin retention in the cytoplasm and altered desmosome structure (Dhitavat et al. [@CR92]; Dhitavat et al. [@CR93]; Sakuntabhai et al. [@CR269]).

On the cell surface, the desmosomal cadherins together with plakoglobin and desmoplakin are sufficient to nucleate a desmosomal plaque (Kowalczyk et al. [@CR195]). Further plaque enlargement and desmoglein clustering are dependent on plakoglobin together with plakophilin (Bornslaeger et al. [@CR55]; Koeser et al. [@CR187]). Therefore, keratinocytes deficient for either plakoglobin or desmoplakin display reduced numbers of desmosomes, disturbed plaque formation and reduced anchorage of cytokeratin filaments (Bierkamp et al. [@CR48]; Vasioukhin et al. [@CR324]). It appears that during desmosome assembly, Dsg3-containing clusters are formed in the beginning, which, upon attachment to cytokeratin filaments, become integrated in desmosomes (Sato et al. [@CR273]). Once they are formed, desmosomes are stable throughout the cell cycle and are not disrupted during mitosis, although the desmosomal components are subjected to a significant turnover with a half-life of about 30 min like it was shown for Dsc 2a (Windoffer et al. [@CR343]). Finally, it has to be emphasized that a reciprocal dependence of desmosomes and adherens junctions seems to exist. This can be concluded from experiments in which expression of N-terminally deleted Dsc 3 or desmoplakin deficiency resulted in impaired formation of both desmosomes and adherens junctions (Hanakawa et al. [@CR143]; Vasioukhin et al. [@CR324]).

Regulation of keratinocyte proliferation by desmosomal cadherins {#Sec19}
================================================================

Evidence is accumulating that desmosomal cadherins such as Dsg 3 regulate keratinocyte proliferation (Muller et al. [@CR231]). It has been shown that autoantibodies from pemphigus vulgaris patients induce continuing keratinocyte proliferation by impaired Dsg 3/plakoglobin signalling, which finally leads to c-Myc overexpression (Muller et al. [@CR231]; Williamson et al. [@CR342], [@CR341]). According to this concept, in healthy epidermis Dsg 3 binding results in inhibition of glycogen synthase kinase 3 (GSK3) via activation of phosphatidylinositol trisphosphate kinase (PI3K) and Akt. In consequence, GSK3 phosphorylation-dependent degradation of plakoglobin is abolished which allows plakoglobin to translocate into the nucleus and to induce growth arrest via suppression of c-Myc (Muller et al. [@CR231]; Williamson et al. [@CR341]).

Desmosome-associated diseases {#Sec20}
=============================

Several diseases have been found in which impaired desmosomal adhesion contributes to pathogenesis. Inactivation of desmosomal function may be reduced by completely different mechanisms including genetic defects of desmosomal components, cleavage of desmosomal cadherins by bacterial toxins and binding of autoantibodies to desmogleins 1, the latter of which is the cause of the autoimmune disease pemphigus. Although altered expression of desmosomal cadherins such as Dsg 2/Dsc 2 and Dsg 3/Dsc 3 have been observed in human carcinomas such as squamous cell carcinoma as well as gastric, colorectal and breast carcinomas, mutations are usually absent (Bazzi and Christiano [@CR37]). Therefore, the role of desmosomal cadherins in cancer is unclear at present.

Genetic diseases {#Sec21}
----------------

Mutations in desmosomal plaque components in humans affect the myocardium as well as the epidermis with its appendages (Table [1](#Tab1){ref-type="table"}). Mutations in genes for the essential desmosomal plaque components desmoplakin and plakoglobin result in heart, skin and hair defects (Bazzi and Christiano [@CR37]; Green and Simpson [@CR136]; McGrath [@CR209]). In contrast, genetic alterations of Dsg 2, Dsc 2 and plakophilin 2 selectively lead to heart defects because these are the only isoforms of their protein families in the myocardium. On the other hand, mutations in Dsg 1 and plakophilin 1, which are primarily expressed in the epidermis, cause skin defects whereas loss of Dsg 4 in hair follicles results in hair loss.

### Genetic heart defects {#Sec22}

Interestingly, all defects of desmosomal components causing heart defects such as desmoplakin, plakoglobin, plakophilin 2, Dsg 2 and Dsc 2 lead to the phenotype of arrhythmogenic right ventricular cardiomyopathy (ARVC) which is clinically characterized by right bundle block and arrhythmia and histologically by fibrofatty replacement of cardiomyocytes, possibly due to impaired cell adhesion caused by loss and alterations of desmosomes (Asimaki et al. [@CR31]; Gerull et al. [@CR125]; McKoy et al. [@CR211]; Pilichou et al. [@CR257]; Rampazzo et al. [@CR260]; Syrris et al. [@CR313]; Heuser et al. [@CR400]). This is in line with embryonic lethality due to myocardial rupture in mice models deficient in these proteins. Therefore, the thinnest parts of the right ventricle are the most severely affected, but left ventricle involvement also occurs (van Tintelen et al. [@CR322]). However, fibrofatty transdifferentiation of cardiomyocytes cannot be simply explained by impaired desmosomal adhesion, but rather seems to be caused by altered wnt/ β-catenin signalling in response to nuclear translocation of plakoglobin (Garcia-Gras et al. [@CR122]).

### Genetic defects of skin and its appendages {#Sec23}

Haploinsufficiency of the gene encoding Dsg 1 results in the autosomal dominant skin disease striate palmoplantar keratoderma (SPPK), which is characterized by linearly arranged thickening of the stratum corneum on the palms, soles, knees, ankles and finger knuckles (Milingou et al. [@CR221]; Rickman et al. [@CR261]). However, blisters are absent indicating that disturbed differentiation is the primary mechanism underyling this entity rather than a loss of keratinocyte adhesive function. Similarly, mutated Dsg 4 leads to autosomal recessive inherited hypotrichosis due to defective hair follicle differentiation, a phenotype related to the lanceolate hair mouse (Kljuic et al. [@CR181]). In contrast, ablation of plakophilin 1 results in the recessive skin-fragility ectodermal dysplasia syndrome, which in 1997 was the first genetic desmosome-associated disease to be described (McGrath [@CR209]). Here, both loss and alterations of desmosomes and lacking insertion of cytokeratin filaments due to inability to recruit desmoplakin cause skin blistering around the mouth as well as on palms and soles accompanied by dystrophic hair and nails (McGrath et al. [@CR210]; McMillan and Shimizu [@CR212]).

### Mutations in plaque proteins with involvement of various tissues {#Sec24}

Mutations in plakoglobin are the cause of Naxos disease in which ARVC and palmoplantar keratoderma are associated with woolly hair (McKoy et al. [@CR211]). Interestingly, in contrast to plakoglobin-deficient mice (Bierkamp et al. [@CR47]), acantholysis is absent indicating that some mechanical functions of plakoglobin are maintained in these patients.

The most variable phenotypes are the consequence of desmoplakin alterations. An autosomal recessive disorder with dilated cardiomyopathy, keratoderma and woolly hair called Carvajal syndrome is comparable to Naxos disease (Norgett et al. [@CR241]). Haploinsufficiency leads to SPPK, whereas non-sense mutations are accompanied by skin fragility leading to blisters in the face as well as on extremities and trunk and also with wolly hair (Armstrong et al. [@CR27]; Whittock et al. [@CR337], [@CR338]). However, the most severe disorder is lethal acantholytic epidermolyis bullosa, which is caused by C-terminally truncated desmoplakin and was fatal in a 10-day-old hair and nailless newborn due to extensive blistering leading to transcutaneous fluid loss (Jonkman et al. [@CR170]). On the ultra-structural level, desmosomes were reduced in desmoplakin-related SPPK similar to SPPK caused by mutations in Dsg 1 (Wan et al. [@CR328]), but not in lethal acantholytic epidermolysis bullosa. However, desmosome shedding, alterations of desmosomal plaques and impaired cytokeratin insertion were typically associated with desmoplakin mutations (Jonkman et al. [@CR170]; Norgett et al. [@CR241]; Wan et al. [@CR328]). At present, it is unclear why different mutations affect different tissues.

Infectious diseases {#Sec25}
-------------------

Staphylococcal scalded skin syndrome (SSSS), which was first described by Ritter von Rittershain in 1878, is the systemic variant of epidemic pemphigus neonatorum or sporadic bullous impetigo and is characterized by superficial epidermal splitting accompanied by fever, erythema and skin tenderness (Farrell [@CR108]; Lyell [@CR203]; Stanley and Amagai [@CR308]). Most cases are caused by staphylococcal exfoliative toxin (ET), a serine protease, which has been shown to selectively cleave Dsg 1 between EC 3 and 4 in conformation-dependent manner, but not Dsg 3 or E-cadherin (Table [1](#Tab1){ref-type="table"}) (Amagai et al. [@CR16], [@CR18]; Hanakawa et al. [@CR144]; Melish and Glasgow [@CR214]). Assuming that ET does not cleave other superficially expressed desmosomal cadherins such as Dsg 4 or Dsc 1, SSSS is a good example that extensive epidermal blistering can be induced by proteolytic cleavage of a single adhesion molecule. According to its bacterial pathogenesis, SSSS can be effectively treated with antibiotics (Stanley and Amagai [@CR308]).

Pemphigus {#Sec26}
=========

Pemphigus is an autoimmune blistering skin disease, which is characterized by intraepidermal blistering (Lever [@CR200]). The two major types of pemphigus are the more severe pemphigus vulgaris (PV), which accounts for 80--90% of cases, and pemphigus foliaceus (PF) (Bystryn and Rudolph [@CR65]; Schmidt et al. [@CR284]; Stanley and Amagai [@CR308]). Pemphigus is a rare disease with a yearly incidence of 0.75--5 cases per million and apart from being present in humans, is also found in horses, dogs and cats. In contrast to other autoimmune diseases, which primarily affect women, pemphigus is equally distributed between both genders, and is diagnosed mostly between the fourth and sixth decades. In PV, there are two main forms, the mucosal-dominant and the mucocutaneous type. In both cases, the disease most commonly begins with painful non-healing ulcerations not only in the mucous membranes of the mouth, but also in the larynx, nose and vagina. Later on, flaccid blisters may occur on the scalp, trunk, groin and axillae, which easily rupture, leaving sharply outlined erosions and heal without scarring (Fig. [6](#Fig6){ref-type="fig"}). In contrast to PV, PF only affects the epidermis and because epidermal splitting is restricted to the superficial epidermis, lesions appear as crusted erosions on the upper torso, face and scalp. It has to be mentioned that pemphigus can be induced by drugs such as penicillamine, penicillin, captopril and β-blockers and also can occur as a paraneoplastic entity accompanying or preceding lymphoma and lung carcinoma (Yeh et al. [@CR349]). Moreover, in South America an endemic form of PF, called Fogo selvagem, exists, which is thought to be transmitted by insect vectors (Aoki et al. [@CR24]; Diaz et al. [@CR94]). Currently, the therapy of pemphigus is based on immunosupression and reduction of autoantibody load. Conventional therapy includes high-dose corticosteroids, intravenous immune globulin and cytotoxic agents. Before systemic corticosteroids were available, 75% of PV patients died within a year. Second-line therapies for refractory PV include rituximab, an antibody directed against B cell CD20, which reduces autoantibody-producing B cells as well as plasmapheresis to physically remove autoantibodies (Ahmed et al. [@CR2]; Shimanovich et al. [@CR295]). Fig. 6Clinical phenotype of Pemphigus vulgaris and Pemphigus foliaceus. Patients suffering from the mucocutaneous form of pemphigus vulgaris (*PV*) usually have flaccid blisters and erosions on the trunk (**a**) accompanied by mucosal ulcerations in the mouth (**b**). In contrast, Pemphigus foliaceus patients are characterized by crusted epidermal erosions (**c**) whereas involvement of mucous membranes is absent

Histology and autoantibody profile in pemphigus {#Sec27}
-----------------------------------------------

Besides the clinical phenotype, diagnosis of pemphigus is based on histology and the patients' autoantibody profile (Bystryn and Rudolph [@CR65]). The histologic hallmark of pemphigus is acantholysis, i.e. loss of cell--cell adhesion between keratinocytes. In PV, the epidermal cleavage plane is located in the deep epidermis, usually right above the basal layer (Fig. [7](#Fig7){ref-type="fig"}). In contrast, in PF, epidermal splitting occurs between granular layers. Skin blisters can be induced by rubbing on healthy-appearing epidermis, a phenomenon referred to as Nikolsky sign. Fig. 7Typical histology of epidermal lesions from pemphigus patients. Hematoxylin eosin-stained paraffin sections from PV (**a**) and PF (**b**) patients showed suprabasal epidermal cleavage in the PV and superficial granular blistering in PF. *Scale bar* is 50 μm

Autoantibodies in pemphigus are sufficient to cause blistering in human skin in vivo and in vitro (Anhalt et al. [@CR22]; Schiltz and Michel [@CR277]). In contrast to other autoimmune blistering skin diseases such as bullous pemphigoid or epidermolysis bullosa acquisita (Sitaru and Zillikens [@CR301]; Yancey [@CR348]), pemphigus antibodies do not require the complement system or leukocytes to induce blisters in vivo (Anhalt et al. [@CR23]). It is generally accepted that PV and PF are characterized by different autoantibody profiles, which generally correlate with disease activity (Bystryn and Rudolph [@CR65]; Harman et al. [@CR146]; Ishii et al. [@CR161]; Stanley and Amagai [@CR308]; Stanley et al. [@CR309]; Yeh et al. [@CR349]). Patients suffering from mucosal-dominant PV usually have antibodies directed against Dsg 3 but not Dsg 1, whereas mucocutaneous PV is characterized by both Dsg 3 and Dsg 1 autoantibodies (Amagai et al. [@CR15]; Ding et al. [@CR95]; Jamora et al. [@CR165]; Miyagawa et al. [@CR224]). In contrast, in PF patients usually antibodies against Dsg 1 but not Dsg 3 are detected (Amagai et al. [@CR15]). However, it is also known that in some cases this correlation between the clinical phenotype and the autoantibody profile was not found (Baykal et al. [@CR35]; Jamora et al. [@CR165]; Yoshida et al. [@CR352]; Zagorodniuk et al. [@CR353]).

Over the last decade, there is a debate whether these autoantibodies against desmosomal cadherins are pathogenic (Amagai et al. [@CR19]). It has been shown by passive transfer of affinity-purified Dsg antibody fractions as well as by depletion of pathogenic activity by absorption against desmoglein extracellular domains that Dsg 1 antibodies in PF and the combination of Dsg 1 and Dsg 3 autoantibodies in PV as well as in paraneoplastic pemphigus are sufficient to induce skin blistering (Amagai et al. [@CR12], [@CR10], [@CR9], [@CR8], [@CR14]; Koulu et al. [@CR192]; Mahoney et al. [@CR205]). An active PV mouse model in which Dsg 3-deficient mice were immunized with Dsg 3 before splenocytes from these animals were transferred to lymphopenic Rag-2-deficient mice supported the notion that Dsg 3 antibodies alone can cause mucosal erosions (Amagai et al. [@CR17]). Similar in keratinocyte cultures, depletion of Dsg 1-specific antibodies from PF-IgG by preincubation with recombinant Dsg 1 but not after preincubation with VE-cadherin completely abolished keratinocyte dissociation (Waschke et al. [@CR331]).

Pemphigus IgG were found to include a plethora of more than 20 different autoantibodies against keratinocyte antigens such as antibodies against Dsg 1, Dsg 4, Dsc 1-3, desmoplakin, plakoglobin and E-cadherin and several other proteins not associated with cell junctions (Amagai et al. [@CR19]; Evangelista et al. [@CR103]; Kljuic et al. [@CR181]; Korman et al. [@CR190]; Nguyen et al. [@CR237]). For instance, in all PF sera as well as in 79% of mucocutaneous PV sera, autoantibody activities against E-cadherin were detected, most of which were due to Dsg 1 autoantibodies cross-reacting with E-cadherin (Evangelista et al. [@CR103]). Some of the different autoantibodies have clearly been shown not to be pathogenic such as the Dsg 4-cross-reacting Dsg 1 antibodies in PF (Nagasaka et al. [@CR233]). Therefore, similar to other autoimmune diseases, the pathogenetic relevance of autoantibodies against a specific protein in pemphigus has to be challenged until it has been convincingly demonstrated (Amagai et al. [@CR19]). However, it has been reported that antibodies others than those directed to desmogleins also contribute to epidermal blistering because PV-IgG not containing Dsg 1 antibodies were effective to cause blistering in Dsg 3-deficient mice (Nguyen et al. [@CR237]). It is possible that these antibodies include antibodies to cholinergic receptors and to pemphaxin, which have both been detected in 85% of PV and PF sera (Grando [@CR133]; Nguyen et al. [@CR236]). The pathogenic relevance of antibodies against cholinergic receptors was concluded from experiments where preincubation of monkey oesophagus with PV-IgG blocked staining by a rabbit acetylcholine receptor antibody and the fact that this antibody induced keratinocyte dissociation in culture (Nguyen et al. [@CR235]). However, antibodies against pemphaxin alone were not sufficient to induce skin blistering (Nguyen et al. [@CR236]). Moreover, it has not been demonstrated so far that autoantibodies from pemphigus patients, which target cholinergic receptors are capable to induce acantholysis. Therefore, at present it is safe to believe that epidermal blistering in pemphigus is primarily caused by antibodies against Dsg 1 and Dsg 3. These pathogenic antibodies in PV and PF mainly belong to the IgG 4 and IgG 1 subclasses (Bhol et al. [@CR46]; Rock et al. [@CR263]; Spaeth et al. [@CR306]).

The knowledge that autoantibodies against desmosomal cadherins are sufficient to induce acantholysis in complement- and leukocyte-independent manner makes pemphigus one of the best-characterized models to study the direct mechanisms underlying autoimmune diseases. Besides the role of autoantibodies, the contribution of Dsg 3 autoreactive T helper (Th) cells has also been characterized for PV and endemic PF (Hertl et al. [@CR156]). Th1 and Th2 cells in PV recognize the extracellular domain of Dsg 3 when presented on the HLA class II alleles HLA-DRβ1\*0402 and HLA-DQβ1\*0503, whereas in Fogo selvagem patients HLA-DRβ1\*0402 and HLA-DRβ1\*0101 were most common. In PV patients as well as in healthy carriers of the PV-associated HLA II alleles, Dsg 3 and Dsg 1-autoreactive T cells were found. In healthy individuals, Th1 cells with characteristics of regulatory T (Tr1) cells which inhibit T cell activation were most prevalent. In contrast, in PV patients the levels of Tr1 cells were reduced while Th2 cells were increased (Veldman et al. [@CR325]). Therefore, it is possible that an imbalance of autoreactive Tr1 and Th 2 cells plays a role in the induction of PV by promoting the proliferation of anti-Dsg 3 producing B cells.

The mechanisms underlying pemphigus skin blistering {#Sec28}
---------------------------------------------------

As a first concept it was proposed that proteolytic cleavage of molecules responsible for intercellular adhesion was the mechanism underlying pemphigus skin blistering. Later on, with the identification of desmosomal cadherins as the target antigens of pemphigus autoantibodies and with more sophisticated cell biologic tools at hand, the ideas of direct antibody-mediated inhibition and of indirect signalling-mediated reduction of desmoglein binding were developed (Fig. [8](#Fig8){ref-type="fig"}). Fig. 8The two principal mechanisms underlying pemphigus skin blistering. Two principal mechanisms have been proposed by which autoantibodies specific for Dsg 1 and Dsg 3 could impair desmosomal adhesion. First, antibodies could directly interfere with desmoglein transinteraction (**a**). Second, antibody binding has been shown to trigger intracellular signalling pathways, which indirectly results in loss of desmoglein-mediated binding (**b**)

### Proteolytic cleavage of desmosomal cadherins {#Sec29}

Proteolytic cleavage of cell adhesion molecules has first been suggested to be involved in pemphigus acantholysis because protease inhibitors blocked pemphigus IgG-induced cell detachment in culture (Farb et al. [@CR106]). Moreover, plasminogen activator activity and expression of the urokinase-type plasminogen activator receptor (uPAR) system were found to be increased following treatment with PV- and PF-IgG/serum in keratinocytes in vitro as well as in PV patients' skin (Feliciani et al. [@CR112]; Hashimoto et al. [@CR147]; Lo Muzio et al. [@CR201]; Schaefer et al. [@CR274]; Seishima et al. [@CR288]; Yamamoto et al. [@CR347]), possibly via phospholipase C (PLC)-mediated signalling (Esaki et al. [@CR101]). Anti-uPA antibodies and a PA inhibitor were sufficient to block acantholysis induced by PV- or PF-IgG in several studies (Feliciani et al. [@CR112]; Hashimoto et al. [@CR147]; Morioka et al. [@CR227]) but not in that by Schuh et al. ([@CR285]). However, a definitive evaluation of the uPAR system for pemphigus acantholysis became possible since a study using uPA- and tissue PA-deficient mice showed extensive skin blistering in response to PV- and PF-IgG (Mahoney et al. [@CR205]). Thus, the plasminogen activator system does not appear to be essential for pemphigus skin blistering but may aggravate the phenotype, especially when secondary inflammatory mediators such as IL-1α and TNF-α are released (Feliciani et al. [@CR111], [@CR112]).

The same may hold true for other proteases such as matrix metalloproteinases (MMP) or proteases of the ADAM (a disintegrin and metalloproteinase) family. MMP-9, which was overexpressed but not activated following treatment with PV serum was reported to specifically cleave Dsg 3 during apoptosis (Cirillo et al. [@CR81], [@CR84]). ADAM17 on the other hand, was upregulated by activation of the epidermal growth factor receptor (EGFR) and caused shedding of Dsg 2 (Bech-Serra et al. [@CR38]; Santiago-Josefat et al. [@CR272]). These results may be important for PV because EGFR activation was observed following treatment with PV-IgG (Chernyavsky et al. [@CR73]; Frusic-Zlotkin et al. [@CR117]). The presence of proteolytic enzymes in PV sera may also explain why IgG-depleted PV sera were found to be pathogenic in culture (Cirillo et al. [@CR83]). However, because no direct evidence was provided that MMP-9 or ADAM17 or any other proteinase cleaves members of the Dsg family in pemphigus, the significance of these findings for acantholysis in pemphigus is unclear and the specific proteolysis hypothesis proposed for pemphigus requires further experimental substantiation (Cirillo et al. [@CR85]). Nevertheless, the fact that specific cleavage of Dsg 1 by staphylococcal exfoliative toxin in bullous impetigo is sufficient to cause a histologic phenotype comparable to PF (Amagai et al. [@CR16]; Hanakawa et al. [@CR144]) indicates that, in principle, specific proteolysis could be an effective mechanism in pemphigus.

### Direct inhibition of desmoglein binding {#Sec30}

Since it was discovered that autoantibodies in pemphigus are directed to desmosomal adhesion molecules, it was believed that these autoantibodies might directly interfere with desmoglein binding (Fig. [8](#Fig8){ref-type="fig"}) (Amagai et al. [@CR8]; Jones et al. [@CR168]; Koulu et al. [@CR192]), a mechanism also refered to as "steric hindrance"(Sharma et al. [@CR292]). This model is attractive because it has been shown that autoantibodies against Dsg 3 and Dsg 1 in PV and PF patients primarily target the aminoterminal part of the EC 1 domain (Futei et al. [@CR119]; Hacker-Foegen et al. [@CR141]; Ishii et al. [@CR162]; Muller et al. [@CR232]; Sekiguchi et al. [@CR290]). The EC 1 domain, according to morphologic studies on desmoglein transinteraction in desmosomes, is increasingly recognized as the part of the desmosomal cadherin ectodomain, responsible for *trans*-interaction (Al-Amoudi et al. [@CR5]; He et al. [@CR153]) and may harbour the putative transadhesive interface, based on data from the crystal structure of classical cadherins (Boggon et al. [@CR51]; Overduin et al. [@CR245]; Shapiro et al. [@CR291]). Moreover, it seems that autoantibody reactivity to the aminoterminal parts (EC 1) of the Dsg 3 ectodomain correlates with high disease activity as well as epidermal or mucosal involvement in PV although the titers of these antibodies do not show this correlation (Amagai et al. [@CR9]; Muller et al. [@CR230], [@CR232]; Salato et al. [@CR270]).

First functional data that anti-Dsg 3 antibodies in PV may directly interfere with Dsg 3 binding were provided using monoclonal antibodies derived from the active PV mouse model (Amagai et al. [@CR17]). AK 23, which was directed against the aminoterminal part of EC 1 was found to be pathogenic and capable to induce epidermal blistering in vivo, at least when PF-IgG or exfoliative toxin A was added to inactivate Dsg 1 (Shimizu et al. [@CR298]; Tsunoda et al. [@CR320]). Antibodies to other parts of the Dsg 3 extracellular domain such as AK 9 and AK 18 were ineffective to induce blisters. Recently, by using single-molecule atomic force microscopy (AFM), it was shown that PV-IgG as well as AK 23 directly interfered with homophilic Dsg 3 binding under cell free conditions (Heupel et al. [@CR157]) which supports the hypothesis of direct inhibition of Dsg 3 binding in PV (Stanley and Amagai [@CR308]). However, no direct inhibition of Dsg 1 binding by PV-IgG and PF-IgG was detected by AFM. These autoantibodies induced keratinocyte dissociation and reduced binding of both Dsg 3- and Dsg 1-coated microbeads to the surface of cultured keratinocytes, as revealed by laser trapping (Heupel et al. [@CR157]; Waschke et al. [@CR331]). These data suggest that autoantobodies interfere with Dsg 1 binding rather by indirect, cell-dependent mechanisms.

Finally, it has to be noted that, if direct inhibition occurs, it is not possible to discriminate at present whether interference with Dsg 3 binding in PV was mediated by steric hindrance, i.e. by blocking *trans*-interaction of desmoglein molecules by the bound autoantibody, or rather by allosteric effects, i.e. autoantibody-induced conformational changes of the Dsg 3 ectodomain, which in turn interfere with Dsg 3 transinteraction. An antibody directed against the putative transadhesive interface may directly induce steric hindrance, whereas antibodies directed against other parts of the desmoglein ectodomain could indirectly inhibit desmoglein binding by allosteric mechanisms. The fact that AK 18 and AK 9, which were directed to the middle and the carboxyterminal parts of the Dsg 3 ectodomain, were not pathogenic and did not directly interfere with Dsg 3 binding suggests that these specific antibodies were not capable of causing allosteric hindrance (Heupel et al. [@CR157]; Tsunoda et al. [@CR320]). On the other hand, an antibody directed against the EC2 domain, although this part of the molecule may not be involved in transinteraction, might be large enough to cause steric hindrance of Dsg 3 transinteraction. Therefore, "direct inhibition", instead of "steric hindrance" of desmoglein binding should be used until discrimination between steric and allosteric effects is possible.

### Desmoglein compensation in pemphigus {#Sec31}

The desmoglein compensation hypothesis was proposed to explain the different clinical phenotypes of PV and PF on the basis of their different autoantibody profiles (Amagai [@CR7]; Payne et al. [@CR250]; Sharma et al. [@CR292]; Shirakata et al. [@CR299]; Stanley and Amagai [@CR308]; Udey and Stanley [@CR321]). According to this concept, in the deep epidermis which contains both Dsg 1 and Dsg 3, Dsg 3 compensates for the functional loss of Dsg 1 induced by Dsg 1-specific autoantibodies, resulting in more superficial blistering in PF (Fig. [9](#Fig9){ref-type="fig"}). In PV, when only Dsg 3 antibodies are present, no epidermal blistering would occur because Dsg 1 is considered to compensate for autoantibody-induced loss of Dsg 3 binding. However, acantholysis occurs in mucous membranes where Dsg 3 is assumed to be the predominantly expressed Dsg isoform, leading to the phenotype of mucosal-dominant PV. When autoantibodies to Dsg 1 are also produced in PV, epidermal blistering occurs. However, it is unclear why the cleavage plane is restricted to the deep epidermis in PV since in PF Dsg 1 autoantibodies cause superficial blistering (Fig. [10](#Fig10){ref-type="fig"}). For this reason and other reasons such as the cases of pemphigus in which the autoantibody profiles do not correlate with the clinical phenotype or the presence of other desmosomal cadherin isoforms in the epidermis, this concept has been challenged (Amagai et al. [@CR19]; Bystryn and Rudolph [@CR65]; Muller et al. [@CR229]; Spindler et al. [@CR307]). Fig. 9The desmoglein compensation hypothesis. Based on the different autoantibody profiles in PV and PF together with the findings that Dsg 3 is present in the deep epidermis only whereas Dsg 1 is primarily expressed in the superficial epidermis, the desmoglein compensation hypothesis has been proposed to explain the epidermal cleavage planes typical for PV and PF. According to this model, blistering in PF affects the superficial epidermis because Dsg 3 is present in the deep epidermis to compensate for the autoantibody-induced loss of Dsg 1 binding. In PV, epidermal involvement would occur only when autoantibodies against both Dsg 1 and Dsg 3 are present because Dsg 1 is found in all epidermal layers and could compensate for loss of Dsg 3 binding when antibodies to Dsg 3 are solely presentFig. 10Immunostaining of Dsg 1 and Dsg 3 in PV lesional epidermis. Epidermis from a patient with mucocutaneous PV was stained for Dsg 1 (**a**) and Dsg 3 (**b**). A merge of both panels is shown in c. Both Dsg 1 and Dsg 3 are expressed in the basal layer underneath the blister as well as in keratinocytes in the blister roof. However, Dsg 3 staining appears to be fragmented throughout the epidermis whereas Dsg 1 staining is more continuous. Note that in the level of the cleavage plane the apical membrane of basal cells shows strong immunostaining for Dsg 1 and Dsg 3 (*arrows*). Therefore, based on the desmoglein compensation hypothesis the expression patterns of Dsg 1 and Dsg 3 cannot explain why the cleavage plane is located suprabasally in PV but not in other epidermal layers. *Scale bar* is 20 μm

Experimental support for the desmoglein compensation hypothesis in vivo was obtained in mice. It was shown that PF-IgG were sufficient to cause skin blistering in Dsg 3-deficient mice but not in normal mice (Mahoney et al. [@CR205]). In skin layers where Dsg 1 and Dsg 3 were found, autoantibodies against both desmogleins were required for blistering. In line with these findings, forced expression of Dsg 3 in the superficial epidermis abolished the ability of PF-IgG to induce acantholysis in mice (Wu et al. [@CR345]). In contrast, in human skin and in cultured human keratinocytes in vitro, PF-IgG were effective to induce acantholysis despite of the presence of both Dsg 1 and Dsg 3 (Spindler et al. [@CR307]). The discrepancy between these conflicting findings may be explained in part by the notion that the desmoglein compensation hypothesis is based on the following two assumptions: (1) the expression pattern of Dsg 3 and Dsg 1 do not substantially overlap in epidermal and mucosal layers where the cleavage plane in PV and PF is located. (2) Dsg 1- and Dsg 3-specific autoantibodies only lead to inactivation of either Dsg 1 or Dsg 3, respectively. Because of the latter, the desmoglein compensation hypothesis has been used to promote the idea that autoantibodies reduce Dsg binding by direct inhibition rather than by unspecific proteolysis (Mahoney et al. [@CR205]).

Regarding the distribution of Dsg 1 and Dsg 3, it is important to note that Dsg 3 expression patterns in specific epidermal layers are different in mice and men. In mice, expression of Dsg 3 is restricted to the basal and immediately suprabasal epidermal layer (Mahoney et al. [@CR206], [@CR205]). In human skin, when PV and PF were used for staining, a similar staining pattern was revealed (Amagai et al. [@CR13]; Shimizu et al. [@CR296]). In contrast, when specific antibodies or in situ hybridisation were used for Dsg 3 mapping in human epidermis, it was demonstrated that Dsg 3 is present throughout the spinous layers and thus Dsg 3 distribution showed substantial overlap with expression of Dsg 1 (Arnemann et al. [@CR29]; Mahoney et al. [@CR206]; Spindler et al. [@CR307]). However, immunostaining of human epidermis using another monoclonal antibody detected expression of Dsg 3 in the lower epidermis only (Wu et al. [@CR345]). In oral mucosa, equally strong expression of Dsg 1 and Dsg 3 was found throughout the epithelium when specific antibodies were used (Mahoney et al. [@CR206]), whereas Dsg 1 staining intensity was found to be much lower when PV-IgG were used for immunstaining (Shirakata et al. [@CR299]). Taken together, the expression patterns of Dsg 1 and Dsg 3 broadly overlap in human epidermis and appear to be identical in oral mucosa.

With respect to the second assumption the desmoglein compensation is based on, i.e. selective inactivation of Dsg 1 but not of Dsg 3 by Dsg 1-specific antibodies, it was shown recently that both PF-IgG (only containing Dsg 1-specific antibodies) and PV-IgG from patients with only Dsg 3-specific antibodies were equally effective to reduce binding of Dsg 1- and Dsg 3-coated beads to the surface of cultured keratinocytes (Heupel et al. [@CR157]; Spindler et al. [@CR307]). These data indicate that PV-IgG and PF-IgG can reduce binding of Dsg 1 and Dsg 3, at least on the keratinocyte cell surface. Taken together, the relevance of desmoglein compensation for pemphigus pathogenesis in humans cannot be concluded from experiments in mice, especially because distribution patterns of Dsg 1 and Dsg 3 substantially differ in the two species. Therefore, alternative models have to be worked out to explain the different epidermal cleavage planes in PV and PF. These may involve different signalling pathways required for maintenance of desmosomal adhesion in the specific epidermal layers as outlined below.

### Signalling pathways in pemphigus and in desmosome disassembly {#Sec32}

Since it has been shown that PV-IgG upon binding to keratinocytes induced a rapid transient increase of intracellular Ca^2+^ (Seishima et al. [@CR287]), several signalling pathways have been shown to be involved in pemphigus pathogenesis (Fig. [8](#Fig8){ref-type="fig"}) (Kitajima [@CR177]; Lanza et al. [@CR198]; Sharma et al. [@CR292]; Sitaru and Zillikens [@CR301]). Interestingly, evidence has been provided that transadhering non-desmosomal cadherins, for instance Dsg 3, are involved in "outside-in" signalling and that binding of pemphigus IgG interferes with this function (Muller et al. [@CR231]). This can be concluded from experiments which showed that autoantibody binding as well as keratinocyte separation started between desmosomes (Sato et al. [@CR273]; Takahashi et al. [@CR314]) and that non-junctional Dsg 3 and plakoglobin were depleted first before changes in the desmosomal fractions were present (Aoyama and Kitajima [@CR25]; Williamson et al. [@CR341]; Yamamoto et al. [@CR346]). Interestingly, to trigger Dsg-induced signalling, autoantibody-mediated cross-linking of Dsg 3 and Dsg 1 seems not to be required because monovalent Fab fragments and single-chain variants of PV- and PF-IgG were effective to cause skin blistering in vivo and to disrupt the desmosomal plaque in vitro (de Bruin et al. [@CR90]; Ishii et al. [@CR162]; Payne et al. [@CR251]; Rock et al. [@CR262]).

#### Ca^2+^, PLC and PKC {#Sec33}

It was shown that PV-IgG caused a rapid, transient phospholipase C (PLC)-dependent increase of inositol 1,4,5 trisphosphate and of intracellular Ca^2+^ leading to activation of both PKC and plasminogen activator (PA) (Esaki et al. [@CR101]; Kitajima et al. [@CR180]; Memar et al. [@CR215]; Osada et al. [@CR244]; Seishima et al. [@CR287], [@CR289]. Because a chelator of intracellular free Ca^2+^ blocked keratinocyte dissociation in vitro and inhibitors of calmodulin, PLC and PKC were effective to block PV-IgG-induced acantholysis in vivo (Arredondo et al. [@CR30]; Sanchez-Carpintero et al. [@CR271]), it is possible that this signalling pathway may be involved in PV acantholysis. However, because the PA system is not believed to be crucial in this process, PKC signalling may contribute to PV acantholysis by other pathways such as phosphorylation of β-catenin in adherens junctions (Chernyavsky et al. [@CR74]). This hypothesis is supported by experiments, which showed that keratinocyte adhesion was negatively regulated by pharmacologic PKC activation (Kimura et al. [@CR175]).

#### p38MAPK {#Sec34}

Activation of p38MAPK at present is the most promising signalling mechanism to be responsible for acantholysis in pemphigus. It has been demonstrated in vivo that p38MAPK and one of its downstream targets, heat shock protein (HSP) 25, were phosphorylated in response to PV-IgG and PF-IgG and that pharmacologic inhibition of p38MAPK abolished blister formation (Berkowitz et al. [@CR42], [@CR44]). Similarly, p38MAPK and the human homolog HSP 27 were found to be phosphorylated in skin lesions of PV and PF patients (Berkowitz et al. [@CR43]). In cultured human keratinocytes, phosphorylation of p38MAPK and HSP27 occured after 30 min of exposure to PV-IgG (Berkowitz et al. [@CR41]; Kawasaki et al. [@CR173]). However, another study found that activity of p38MAPK was not increased before 120 min and that activity peaked after 240 min of PV-IgG treatment (Chernyavsky et al. [@CR73]). In the latter study it was shown that activation was mediated, at least in part, by Dsg 1- and/or Dsg 3-specific antibodies because Dsg depletion by siRNA reduced p38MAPK activation by 50%. Inhibition of p38MAPK blocked autoantibody-induced keratinocyte dissociation, Rho A inactivation, cytokeratin retraction and reorganization of the actin cytoskeleton (Berkowitz et al. [@CR41]; Chernyavsky et al. [@CR73]; Waschke et al. [@CR332]). These results demonstrate that p38MAPK is involved in the mechanisms leading to acantholysis and that inhibition of p38MAPK could be a beneficial approach to treat pemphigus patients. Nevertheless, based on the finding that activation of p38MAPK can also be a consequence of cell detachment in rat intestinal epithelium (Rosen et al. [@CR265]), it was proposed that p38MAPK activation is a consequence of cell dissociation (Sharma et al. [@CR292]). However, this is unlikely because significant pemphigus-IgG-induced acantholysis usually takes 12--24 h to occur (Berkowitz et al. [@CR42]; Caldelari et al. [@CR66]; Lanza et al. [@CR199]; Mahoney et al. [@CR205]; Nagasaka et al. [@CR233]; Nguyen et al. [@CR237]; Shu et al. [@CR300]; Spindler et al. [@CR307]; Takahashi et al. [@CR314]; Tsunoda et al. [@CR320]; Waschke et al. [@CR331]; Waschke et al. [@CR332]; Williamson et al. [@CR341]).

The mechanisms by which p38MAPK and HSP27 lead to keratinocyte dissociation are largely unclear but may involve reorganization of the keratinocyte cytoskeleton. It has been shown recently that serine phosphorylation of cytokeratin 8 by p38MAPK induced cytokeratin network disassembly (Woll et al. [@CR344]). Similarly, HSP27 was found to associate with cytokeratin filaments and to inhibit assembly of glial fibrillary acidic protein (GFAP) (Perng et al. [@CR253]). Similarly, HSP25 was found to interact with actin filaments and to prevent formation of aggregates of thermally denatured actin (Panasenko et al. [@CR246]). However, because p38MAPK-mediated phosphorylation of HSP27 or HSP 25 promoted actin assembly and stabilized F-actin against depolymerization in response to cytochalasin D or heat shock (Benndorf et al. [@CR40]; Geum et al. [@CR128]; Guay et al. [@CR138]), one would expect that PV-IgG-induced HSP27 phosphorylation also would stabilize actin filaments. Therefore, it is more likely that HSP27 is part of a salvage pathway in response to PV-IgG and does not directly contribute to PV-IgG-induced actin reorganization.

#### Rho A GTPase {#Sec35}

Rho GTPases are important regulators of the cytoskeleton and of cell adhesion (Braga and Yap [@CR57]; Bustelo et al. [@CR61]; Fukata et al. [@CR118]; Jaffe and Hall [@CR164]). In the epidermis, Rac 1 was found not to be crucial for maintaining epithelial integrity but for stem cell differentiation, presumably via negative regulation of c-Myc expression (Benitah et al. [@CR39]; Chrostek et al. [@CR79]). Recently, it has been shown that PV- and PF-IgG-induced epidermal splitting, keratinocyte dissociation, as well as loss of Dsg 1 and Dsg 3 binding in vitro were accompanied by p38MAPK-dependent inactivation of Rho A and that specific activation of Rho A by the bacterial toxin cytotoxic necrotizing factor y (CNFy) abolished these effects (Spindler et al. [@CR307]; Waschke et al. [@CR332]). Moreover, toxin-mediated inactivation of Rho A and Rac 1 resulted in epidermal splitting, keratinocyte dissociation and actin reorganization similar to treatment with pemphigus IgG. Especially, inactivation of Rho GTPases by toxin B caused deep epidermal acantholysis comparable to the effects of PV-IgG. Based on this observation, it is tempting to speculate that the cleavage plane in pemphigus may in part be explained by different, layer-specific signalling pathways important for keratinocyte cohesion.

Because cytokeratin retraction and actin reorganization in response to pemphigus IgG were also abrogated by activation of Rho A, these results suggested that Rho A could be involved in the regulation of desmoglein cytoskeletal anchorage (Waschke et al. [@CR332]). This idea was supported by Triton extraction experiments which showed that Rho A activation reduced Dsg 3 in the non-cytoskeleton bound fraction. Alternatively, Rho GTPases may regulate endocytosis of desmosomal cadherins similar to their role in E-cadherin turnover (Akhtar and Hotchin [@CR4]; Izumi et al. [@CR163]; Kamei et al. [@CR171]). Interestingly, endocytosis and depletion of Dsg3 are increasingly recognized to contribute to pemphigus acantholysis (Calkins et al. [@CR68]; Yamamoto et al. [@CR346]). Taken together, Rho GTPases seem to be important for maintenance of desmosomes and activation of Rho A could be used to develop new strategies in pemphigus treatment.

These data are in contrast to previous findings, which suggested that Rho GTPases are not involved in the regulation of desmosomal adhesion. This was concluded from experiments in keratinocytes which showed that Rac 1 inactivation by transfection with a dominant-inactive mutant as well as inactivation of Rho A by C3 toxin for 25 min was sufficient to displace E-cadherin but not desmoplakin from cell junctions (Braga et al. [@CR58]). These studies led to the hypothesis that Rho GTPases are important regulators of keratinocyte adherens junctions but not desmosomes (Braga and Yap [@CR57]). However, because inactivation of Rho A by a cell-permeable C3 fusion toxin was sufficient to displace Dsg 3 from cell borders after 180 min, the negative results from the early study might be caused by the shorter incubation period (Waschke et al. [@CR332]).

#### Plakoglobin {#Sec36}

Besides its involvement in PV pathogenesis, plakoglobin is important for several aspects of desmosomal adhesion. Plakoglobin deficiency resulted in subcorneal acantholysis, loss of desmosomes, and impaired cytoskeletal anchorage of desmoplakin and desmogleins in vivo and in vitro, supporting the notion that plakoglobin is an important cytoskeletal linker and is crucial for desmosome assembly (Bierkamp et al. [@CR48]; Yin et al. [@CR351]). However, at least in part, plakoglobin functions seem to be compensated by other desmosomal plaque proteins such as plakophilin 1 because a plakoglobin-deficient keratinocyte cell line displayed Dsg 3 cytoskeletal anchorage and keratinocyte aggregation similar to wild-type cells (Caldelari et al. [@CR66]). The linker function of plakoglobin seems to be regulated by tyrosine phosphorylation of plakoglobin because following EGFR activation, phosphorylated plakoglobin remained associated with Dsg 2 but not with desmoplakin (Gaudry et al. [@CR124]). Moreover, plakoglobin phosphorylation was shown to be required for EGFR-induced loss of cell adhesion and to regulate binding of plakoglobin to desmoplakin (Miravet et al. [@CR223]; Yin et al. [@CR351]). These data indicate that plakoglobin is required to integrate the effects from extracellular cues and from different signalling pathways in order to allow coordinated modulation of desmosomal adhesion. In addition, plakoglobin regulates the turn over of desmosomal components because the protein levels of desmogleins as well as of plakoglobin and desmoplakin were decreased in plakoglobin-deficient cells (Yin et al. [@CR351]).

With respect to pemphigus, it has been shown that plakoglobin is critical for PV pathogenesis because keratinocytes from plakoglobin-deficient mice were resistant to PV-IgG-induced keratinocyte dissociation, cytokeratin retraction and disruption of the desmosomal plaque (Caldelari et al. [@CR66]; de Bruin et al. [@CR90]). These studies provided first evidence that direct inhibition of Dsg binding alone cannot account for acantholysis in PV and raised the hypothesis that plakoglobin could be part of a receptor complex required to transfer the signal from autoantibody-bound Dsg 3 into the cell, a phenomenon referred to as "outside-in" signalling (Muller et al. [@CR231]). As outlined above, it has been shown that plakoglobin is involved in c-Myc repression, which is required for keratinocyte differentiation and that PV-IgG by depleting noncytokeratin-anchored plakoglobin on the cell surface also led to c-Myc overexpression (Williamson et al. [@CR341]). However, as discussed below, the role of c-Myc signalling in acantholysis is unclear at present.

#### EGFR {#Sec37}

The involvement of the EGFR in PV pathogenesis has been reported by showing that EGFR activity increased after 30 min and peaked after 60 min of PV-IgG incubation. This was followed by activation of ERK1/2, c-Jun phosphorylation and finally by keratinocyte apoptosis (Chernyavsky et al. [@CR73]; Frusic-Zlotkin et al. [@CR117]). Inhibition of EGFR reduced EGFR signalling as well as apoptosis and acantholysis (Frusic-Zlotkin et al. [@CR117]). This finding was surprising because EGFR signalling usually is considered to promote cell survival and proliferation (Bazley and Gullick [@CR36]; Muller et al. [@CR231]). However, because 60 h were required to induce acantholysis, very high concentrations of IgG (5 mg/ml) were used and activation of p38MAPK was not detected in this study, the significance of these results is unclear.

EGFR could contribute to PV pathogenesis by stimulating desmosome disassembly. It has been shown that EGF-induced loss of keratinocyte aggregation was mediated by plakoglobin phosphorylation, which led to uncoupling of the desmoglein 2-plakoglobin complex from desmoplakin and thus from the cytoskeleton (Gaudry et al. [@CR124]; Yin et al. [@CR351]). Moreover, EGFR seems to negatively regulate the protein levels of desmosomal cadherins, in part by promoting their metalloproteinase-mediated degradation, as well as the incorporation of desmosomal cadherins into the desmosomal plaque (Bech-Serra et al. [@CR38]; Lorch et al. [@CR202]; Santiago-Josefat et al. [@CR272]).

#### Src {#Sec38}

The tyrosine kinase Src is activated by PV-IgG within 30 min and seems to contribute to EGFR and p38MAPK activation because inhibition of Src reduced EGFR and p38MAPK phosphorylation by 45 and 30%, respectively (Chernyavsky et al. [@CR73]). Because Src inhibition reduced PV-IgG-induced loss of keratinocyte cohesion, cytokeratin retraction and apoptosis in vitro and inhition of tyrosin kinases blocked PV-IgG-induced acantholysis in vivo (Chernyavsky et al. [@CR73]; Sanchez-Carpintero et al. [@CR271]), these results indicate that Src is significantly involved in PV acantholysis. Besides activation of p38MAPK and EGFR, a recent study provided another possible underlying mechanism: Src was shown to directly phosphorylate p120catenin in response to PV-IgG, which correlated with the degree of acantholysis (Chernyavsky et al. [@CR74]). Because p120catenin is involved in stabilization of classical cadherins such as E-cadherin on the cell surface as well as in cadherin-dependent regulation of Rho A and Rac 1 activity (Alema and Salvatore [@CR6]; Kowalczyk and Reynolds [@CR193]), Src-mediated phosphorylation of p120catenin may be important for PV pathogenesis.

#### Cholinergic receptors {#Sec39}

The cholinergic system of the human epidermis involves two classes of cholinergig receptors, the nicotinic and the muscarinic acetylcholine receptors (nAChR and mAChR), which in keratinocytes are involved in the regulation of cell--cell and cell--matrix adhesion as well as in cell migration (Grando [@CR133]). As outlined above, it is unclear whether autoantibodies against cholinergic receptors in pemphigus directly contribute to acantholysis. However, it was shown that cholinergic agonists can ameliorate PV acantholysis in vivo and in vitro (Nguyen et al. [@CR239]) and that local application of cholinergic agonists such as pilocarpine had therapeutic effect on oral and skin lesions in PV patients (Iraji and Yoosefi [@CR160]; Namazi [@CR234]). Cholinergic agonists increased protein levels of Dsg 1, Dsg 3 and E-cadherin and antagonists to cholinergic receptors resulted in keratinocyte dissociation, which was paralleled by phosphorylation of these molecules (Grando [@CR133]). Recently, a mechanism by which signalling from cholinergic receptors could directly interfere with PV-IgG-induced effects was demonstrated. The M1 mAChR agonist pilocarpine inhibited PV-IgG-induced acantholysis by reducing serine phosphorylation of β-catenin and Src-mediated tyrosine phosphorylation of p120catenin by activation of the specific protein phosphatases (Chernyavsky et al. [@CR74]). Similarly, an agonist of the α 7 nAChR reduced p120catenin phosphorylation both on the level of Src activation as well as by activation of the tyrosine phosphatase. Moreover, it was shown that M3 and M4 receptors can lead to activation of Rho A and that carbachol, which activates α 3 and α 7 nAChR, activates Rho A, Rac 1 and Cdc42 (Chernyavsky et al. [@CR71], [@CR72]; Ruiz-Velasco et al. [@CR267]), which also might be involved in the inhibition of PV-IgG-induced acantholysis. Taken together, these data indicate that activation of cholinergic receptors could provide a promising strategy to treat PV patients.

#### Regulation of cell cycle and gene expression {#Sec40}

Recent data support the hypothesis that PV-IgG change expression patterns of molecules involved in cell cycle regulation and that these molecules might be involved in acantholysis. As outlined above, PV-IgG-induced plakoglobin depletion resulted in c-Myc overexpression in cultured keratinocytes (Muller et al. [@CR231]; Williamson et al. [@CR341]). Accordingly, c-Myc overexpression was found in the epidermis of PV patients, but interestingly not in PF skin, indicating that this mechanism may only be important for PV (Williamson et al. [@CR342], [@CR341]). Because pharmacologic inhibition of c-Myc as well as of plakoglobin degradation by blocking GSK 3 abrogated pemphigus-IgG-induced skin blistering, these results indicate that this mechanism could also be important to induce acantholysis. However, the findings that c-Myc overexpression was found after 24 h, whereas PV-IgG-induced loss of cell aggregation was observed as early as after 12 h and that c-Myc overexpression was absent in PF skin indicate that c-Myc overexpression likely contributes to ongoing proliferation of keratinocytes in PV, whereas it seems not to be essential for acantholysis. Therefore, other mechanisms must exist in addition to induce keratinocyte dissociation. These mechanisms may, amongst others, involve expression of genes different from c-Myc, which is suggested by the fact that plakoglobin deficiency resulted in protection of keratinocytes from apoptosis, possibly via overexpression of the anti-apoptotic molecule Bcl-X~L~(Dusek et al. [@CR97]).

Similar to c-Myc, cyclin-dependent kinase 2 (cdk2), another kinase involved in the regulation of cell cycle progression, seems to be involved in keratinocyte proliferation and acantholysis in pemphigus (Lanza et al. [@CR199]). PV serum increased protein levels of cdk2 and PV serum-induced acantholysis in vivo was abolished by pharmacologic inhibition of cdk2. Moreover, siRNA-mediated down-regulation of cdk2 blocked cell dissociation in cultured keratinocytes indicating that cdk2 may be important for PV acantholysis in vivo and in vitro. However, at present, it is unclear how continuing keratinocyte proliferation in consequence to increased c-Myc and cdk2 signalling contributes to acantholysis in PV.

One explanation is that reduced expression of desmosomal components in hyperproliferating cells may foster the loss of keratinocyte cohesion in pemphigus. PV-IgG do not only induce direct signalling effects on cell junctions and the cytoskeleton but also change gene expression patterns, which may also contribute to pemphigus pathogenesis. It has been shown by DNA microarray that PV-IgG within 8 h down-regulated transcription of 198 genes including genes encoding for adhesion molecules including Dsg 3 and desmoplakin, cytoskeletal proteins such as different cytokeratins as well as molecules involved in cell cycle regulation such as p53 and cyclin D2 in cultured keratinocytes and that expression of some of these genes was antagonistically regulated by methylprednisolone (Nguyen et al. [@CR238]). When PV serum was used for 24 h, the expression of even more genes was altered. In cultured human keratinocytes, transcription of 231 genes was decreased including Dsc 2 and plakophilin 3 whereas transcription of 329 genes was increased. In vivo, expression of 1114 genes was reduced whereas transcription of 349 other genes was inceased (Lanza et al. [@CR199]). Pharmacologic inhibition of cdk2 blunted the effect of PV-IgG on the expression of most of the genes including desmoplakin and also blocked PV-IgG-induced acantholysis. Thus, it is conceivable that altered desmosome formation may be involved in the mechanisms underlying keratinocyte dissociation in pemphigus.

#### Apoptosis {#Sec41}

Apoptosis has been detected in skin lesions and in perilesional skin of PV and PF patients (Gniadecki et al. [@CR130]; Puviani et al. [@CR259]; Wang et al. [@CR329]) and hallmarks of apoptosis such as DNA fragmentation, increased expression of pro-apoptotic molecules Fas, FasL, Bax, p53, depetion of anti-apoptotic Bcl-2 and FLIP~L~as well as activation of caspases 1, 3 and 8 have been observed following treatment of cultured keratinocytes with PV-IgG or PV serum (Arredondo et al. [@CR30]; Baroni et al. [@CR32]; Chernyavsky et al. [@CR73]; Frusic-Zlotkin et al. [@CR116], [@CR117]; Pelacho et al. [@CR252]; Puviani et al. [@CR259]; Wang et al. [@CR329], [@CR330]). Hence, compelling evidence has been provided for the presence of programmed cell death in PV although the phenotype of acantholytic cells is different from cells undergoing apoptosis (Arredondo et al. [@CR30]). However, for several experiments prolonged incubation times of 48--72 h (Arredondo et al. [@CR30]; Baroni et al. [@CR32]; Frusic-Zlotkin et al. [@CR116], [@CR117]; Wang et al. [@CR329], [@CR330]) were required whereas in most studies from the literature, acantholysis was clearly present after 18--24 h (Berkowitz et al. [@CR42]; Caldelari et al. [@CR66]; Lanza et al. [@CR199]; Mahoney et al. [@CR205]; Nagasaka et al. [@CR233]; Nguyen et al. [@CR237]; Shu et al. [@CR300]; Spindler et al. [@CR307]; Takahashi et al. [@CR314]; Tsunoda et al. [@CR320]; Waschke et al. [@CR331]; Waschke et al. [@CR332]; Williamson et al. [@CR341]). In another study, apoptosis was detected by TUNEL reactivity starting after 6 h of PV-IgG treatment (Chernyavsky et al. [@CR73]). However, in this study, loss of intercellular adhesion was present after 120 min and thus before onset of apoptosis. Therefore, it is conceivable that apoptosis may be an event parallel to or in consequence of acantholysis. On the other hand, it was reported that activated caspase 3 cleaves Dsg 3 (Weiske et al. [@CR334]) and that caspase and calpain inhibitors can block PV-IgG-induced acantholysis in keratinocyte monolayers and in skin organ culture (Arredondo et al. [@CR30]; Wang et al. [@CR329], [@CR330]; Weiske et al. [@CR334]). Taken together, it is unclear at present to which extent PV-IgG-induced acantholysis is caused by apoptosis.

### Targets of signalling pathways in pemphigus {#Sec42}

Pemphigus is a desmosomal disease because pathogenic autoantibodies are directed against Dsg 1 and Dsg 3. Moreover, these antibodies result in the depletion of desmosomal components from the cell surface, alterations of desmosomal plaques and a loss of desmosomes (Aoyama and Kitajima [@CR25]; Aoyama et al. [@CR26]; Calkins et al. [@CR68]; de Bruin et al. [@CR90]; Sato et al. [@CR273]; Shu et al. [@CR300]; Waschke et al. [@CR332]; Williamson et al. [@CR341]; Yamamoto et al. [@CR346]). However, it is unclear at present whether desmosomes are the primary targets of autoantibodies or whether components outside of desmosomes cause disassembly of desmosomes via mechanisms involving adherens junctions or the cytoskeleton, which finally results in acantholysis. The latter hypothesis is supported by the observation that intercellular spaces between desmosomes widen before desmosomes separate (Takahashi et al. [@CR314]).

#### Effects on desmosomes and adherens junctions {#Sec43}

It is well established that pemphigus autoantibodies lead to depletion of desmosomal components from desmosomes as well as from the cell surface. Within 30--60 min, PV-IgG induced internalization and lysosomal degradation of cytoskeleton-unbound Dsg 3 together with plakoglobin (Aoyama and Kitajima [@CR25]; Aoyama et al. [@CR26]; Calkins et al. [@CR68]; Sato et al. [@CR273]; Williamson et al. [@CR341]; Yamamoto et al. [@CR346]). After 24 h, Dsg 3 but not Dsg 2, plakoglobin or desmoplakin was also depleted from the cytoskeletal fractions leading to reduced total cellular Dsg 3 levels (Calkins et al. [@CR68]; Yamamoto et al. [@CR346]). This effect was mediated by Dsg 3-specific antibodies because monoclonal Dsg 3 antibodies such as AK23 were effective to induce Dsg 3 depletion and this effect correlated with the pathogenic activity of these autoantibodies in vivo and in vitro (Shu et al. [@CR300]; Yamamoto et al. [@CR346]). However, no strong correlation between Dsg 3 depletion and keratinocyte dissociation was observed. Dsg 3 depletion was observed in DJM-1 cells at 40% confluence as well as in normal human keratinocytes. In contrast, in confluent HaCaT monolayers, a reduction of Dsg 3 half-life but no depletion of total cellular Dsg 3 was detected (Cirillo et al. [@CR80]; Waschke et al. [@CR332]). Because depletion of Dsg 3 was first found in parallel with serine phosphorylation of Dsg 3, it was suggested that phosphorylation might be required for Dsg 3 degradation (Aoyama and Kitajima [@CR25]; Aoyama et al. [@CR26]; Bystryn and Rodriguez [@CR64]; Rodriguez and Bystryn [@CR264]). However, phosphorylation of Dsg 3 was observed in some studies but not in others, which might be due to different cell culture models indicating that Dsg phosphorylation is not necessary for acantholysis (Chernyavsky et al. [@CR74]; Nguyen et al. [@CR238]).

Some evidence exists that depletion of Dsg 1 may also occur in pemphigus. However, studies to systematically investigate Dsg 1 turnover in pemphigus are lacking. Dsg 1 internalization and decreased immunostaining of Dsg 1 have been observed following treatment with PF-IgG/-serum and PV serum (Cirillo et al. [@CR82]; Waschke et al. [@CR331]). This is in line with previous findings from the literature, which demonstrated that PF-IgG did not bind to keratinocytes in the lower epidermis of PF patients but strongly labelled basal keratinocytes in the epidermis of healthy subjects suggesting that in PF the lower epidermis was depleted from Dsg 1 (Bystryn and Rodriguez [@CR64]; Rodriguez and Bystryn [@CR264]). Taken together, it is unclear at present to which extent Dsg depletion from desmosomes causes antibody-mediated acantholysis. However, even if depletion of desmosomal components occured secondary to keratinocyte dissociation, it likely would further aggravate the loss of keratinocyte cohesion.

The involvement of adherens junctions in pemphigus pathogenesis is unclear at present. It has been shown that formation of adherens junctions is a prerequisite for desmosome assembly and α-catenin-deficient keratinocytes had reduced numbers of desmosmes (Vasioukhin et al. [@CR323]). Because Rho GTPases are known to primarily regulate adhesion mediated by classical cadherins in adherens junctions whereas the requirement of Rho A and Rac 1 activity for maintenance of desmosomal adhesion was reported just recently (Braga and Yap [@CR57]; Fukata et al. [@CR118]; Spindler et al. [@CR307]; Waschke et al. [@CR332]), it was suggested that pemphigus IgG-induced inactivation of Rho A causes disassembly of desmosomes via destabilization of adherens junctions (Sharma et al. [@CR292]). Although alterations of adherens junctions in response to PV-IgG were negligible compared to the effects on desmosomes (Calkins et al. [@CR68]; de Bruin et al. [@CR90]; Muller et al. [@CR231]; Waschke et al. [@CR332]), this scenario cannot be completely ruled out at present. In fact it was reported recently that PV-IgG lead to phosphorylation of β-catenin and p120catenin by PKC and Src, respectively (Chernyavsky et al. [@CR74]). However, more studies are required to address the question how catenin phosphorylation in adherens junctions is associated with keratinocyte dissociation in pemphigus.

#### Effects on the cytoskeleton {#Sec44}

Alterations of the cytoskeleton have been described both in pemphigus skin lesions as well as in keratinocytes exposed to pemphigus autoantibodies,. These effects include dysorganization of cytokeratin filaments, the actin cytoskeleton as well as of microtubules.

First, it has been described that cytokeratin filaments become detached from cell junctions and accumulate in the perinuclear region, a phenomenon commonly referred to as "keratin retraction" (Berkowitz et al. [@CR41]; Caldelari et al. [@CR66]; Calkins et al. [@CR68]; Chernyavsky et al. [@CR73]; Jinbu et al. [@CR167]; Kitajima et al. [@CR179]; Waschke et al. [@CR332]; Wilgram et al. [@CR339], [@CR340]; Williamson et al. [@CR341]). It was shown that cytokeratin retraction could be detected as early as 4--6 h after addition of PV-IgG, i.e. when first alterations of desmosomes became visible, and was fully established after 24 h (Berkowitz et al. [@CR41]; Calkins et al. [@CR68]; Chernyavsky et al. [@CR73]). However, because no cytokeratin filament reorganization was observed before cell detachment and the desmosomes of acantholytic cells remained anchored to cytokeratin filament bundles (Kitajima et al. [@CR178]; Shimizu et al. [@CR297]; Spindler et al. [@CR307]), it appears that cytokeratin retraction is not required for acantholysis but may be a secondary event.

Recent studies demonstrated that acantholysis in pemphigus was paralleled by alterations of actin filaments including increased stress fiber formation as well as fragmentation of actin filament bundles. Moreover, pharmacological inhibition of pemphigus IgG-induced acantholysis also was effective to reverse the effects on the cytoskeleton (Berkowitz et al. [@CR41]; Spindler et al. [@CR307]; Waschke et al. [@CR331]; Waschke et al. [@CR332]). Similarly, microtubule distribution was found to be altered by pemphigus IgG (Kitajima et al. [@CR178]). Taken together, pemphigus IgG cause profound cytoskeletal reorganization but it is unclear at present whether these effects contribute to acantholysis or are triggered consequent to keratinocyte dissociation. Nevertheless, it is likely that alterations in the cytoskeleton may account for the changes in cell shape during keratinocyte dissociation, which seem to start between existing desmosomes (Bystryn and Grando [@CR63]; Takahashi et al. [@CR314]).

### The role of the different mechanisms in blister formation {#Sec45}

As outlined above, both direct and indirect mechanisms finally leading to a loss of desmoglein-mediated adhesion have been found to be involved in pemphigus acantholysis. At present, compelling evidence indicates that acantholysis in PV and in PF is initiated by cellular signalling pathways rather than by direct inhibition of Dsg binding (Fig. [11](#Fig11){ref-type="fig"}). This was first shown using plakoglobin-deficient keratinocytes, which were resistant against PV-IgG-induced acantholysis and was further supported by the findings that inhibition of p38MAPK and activation of Rho A is sufficient to abolish PV-IgG and PF-IgG-induced skin blistering (Berkowitz et al. [@CR41], [@CR42], [@CR44]; Caldelari et al. [@CR66]; Waschke et al. [@CR332]). Moreover, low temperature-abrogated keratinocyte dissociation but not antibody binding to the keratinocyte cell surface indicating that direct inhibition of cadherin transinteraction by autoantibody binding is not sufficient to cause acantholysis (Calkins et al. [@CR68]). If extracellular autoantibody-mediated direct inhibition of Dsg binding would be the primary cause of acantholysis, it is hard to imagine how this process should be blocked by modified intracellular signalling or low temperature. It is possible that antibody-mediated direct inhibition of Dsg binding may contribute to trigger cellular signalling events (Muller et al. [@CR231]; Sharma et al. [@CR292]; Tsunoda et al. [@CR320]). However, because PF-IgG were shown to induce cellular signalling events but not to directly reduce Dsg 1 binding, it seems that direct inhibition of Dsg transinteraction is not essential to alter Dsg-mediated signalling (Heupel et al. [@CR157]; Waschke et al. [@CR331]). Fig. 11The mechanisms involved in pemphigus acantholysis. Accumulating evidence indicates that PV-IgG and PF-IgG initiate keratinocyte dissociation via intracellular signalling pathways including p38 MAPK, Rho A and plakoglobin (PV only). In addition, other mechanisms such as direct inhibition of Dsg 3 binding and Dsg 3 depletion from desmosomes as well as other signalling events seem to contribute to PV pathogenesis, whereas their role for acantholysis in PF is unclear. These mechanisms may account for the more severe clinical phenotype of PV compared to PF. *PLC* phospholipase C, *PKC* protein kinase C, *cdk 2* cyclin-dependent kinase 2, *EGFR* epidermal growth factor receptor

It is tempting to speculate that the clinical phenotype of PV may be more severe compared to PF because additional mechanisms could be involved in PV (Fig. [11](#Fig11){ref-type="fig"}). Indeed, some mechanisms have only been found to contribute to acantholysis in PV but not in PF. For instance, direct inhibition of Dsg 3 transinteraction was found in PV but not in PF under conditions where antibodies caused acantholysis (Heupel et al. [@CR157]). Therefore, it is possible that direct inhibition as a second pathway to reduce Dsg 3 binding in PV may explain the more severe phenotype of PV. Similarly, depletion of Dsg 3 has been convincingly shown in PV whereas depletion of Dsg 1 in both PV and PF is less clear (Yamamoto et al. [@CR346]). Moreover, altered plakoglobin signalling leading to c-Myc overexpression was found in PV patients's skin but not in PF (Williamson et al. [@CR342], [@CR341]). Other pathways have been investigated for PV only whereas data for PF are lacking. As outlined above, inhibitors of calmodulin, PKC, EGFR, cdk2 as well as of tyrosin kinases have been shown to inhibit PV-IgG-induced acantholysis.

Finally, it has to be emphasized that desmoglein proteolysis, mechanical stress as well as secondary changes for example in the extracellular Ca^2+^concentration might contribute to skin blistering. For instance, acantholysis may foster skin blistering by derangement of the epidermal Ca^2+^gradient, which in turn would result in loss of desmosomal cadherin binding, especially when the tight junctions of the granular layer are affected.

Concluding remarks {#Sec46}
==================

The major goal for the future is to elucidate the primary signalling pathways responsible for the diverse effects of pemphigus IgG such as inhibition of desmoglein binding, depletion of desmosomal components, loss of desmosomes, reorganization of the cytoskeleton and finally the induction of acantholysis. Other pathways will be identified to represent salvage mechanisms to rescue keratinocyte cohesion (Grando [@CR134]). Moreover, future experiments may reveal how the different signalling pathways are involved in the regulation of desmosomal adhesion in the specific epidermal layers. This knowledge may elucidate why the cleavage planes in PV and PF usually are different. The second goal is to characterize whether acantholysis in pemphigus is caused by mechanisms directly targeting desmosomes or whether cellular signalling pathways regulate desmosomal adhesion via reorganisation of the cytoskeleton or via other types of cell contacts such as adherens junctions.

The author is grateful to Detlev Drenckhahn for helpful comments and for critically reading the manuscript as well as to Michael Christof for figure design. Photographs of pemphigus patients were generously contributed by D. Zillikens and E. Schmidt (both Department of Dermatology, University of Lübeck). Special thanks to the members of the PTF (Wolfgang-Moritz Heupel, Volker Spindler, Peter Engerer, Judith Gutberlet, Seraj Khan) for inspiring discussion. The author's work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 487, TP B5 to Detlev Drenckhahn) and the IZKF Würzburg (TP A-51).
